10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(MARK ONE)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED April 30, 2016

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM          TO          

COMMISSION FILE NUMBER: 001-15331

CROSSROADS SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

DELAWARE	74-2846643
(State or other jurisdiction of	(I.R.S. Employer Identification No.)
incorporation or organization)
11000 NORTH MOPAC EXPRESSWAY
SUITE 150
AUSTIN, TEXAS	78759
(Address of principal executive offices)	(Zip code)

(512) 349-0300

(Registrant’s telephone number, including area code)

Indicate by check mark whether registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  x  Yes   ¨  No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  x  Yes   ¨  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

¨  Large Accelerated Filer ¨  Accelerated Filer  ¨  Non-Accelerated Filer x  Smaller Reporting Company 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)  ¨  Yes   x  No

As of June 14, 2016, Registrant had outstanding 24,509,435 shares of common stock, par value $0.001 per share.

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

FORM 10-Q

QUARTER ENDED April 30, 2016

TABLE OF CONTENTS

		PAGE
	PART I   FINANCIAL INFORMATION
Item 1.	Financial Statements	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	21
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	27
Item 4.	Controls and Procedures	27
	PART II   OTHER INFORMATION
Item 1.	Legal Proceedings	28
Item 1A.	Risk Factors	30
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	30
Item 3.	Defaults Upon Senior Securities	30
Item 4.	Mine Safety Disclosures	30
Item 5.	Other Information	30
Item 6.	Exhibits	31

2

PART I- FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS –

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

	April 30,			October 31,
ASSETS	2016			2015
	(unaudited)
Current assets:
Cash and cash equivalents	$	2,994		$	5,314
Restricted cash		3,122			6,478
Total cash, cash equivalents and restricted cash		6,116			11,792
Accounts receivable, net of allowance for doubtful accounts of $3 and $5, respectively		1,056			656
Current assets of discontinued operations		-			1,544
Prepaid expenses and other current assets		227			218
Total current assets		7,399			14,210
Non-current assets of discontinued operations		-			562
Other assets		140			141
Total assets	$	7,539		$	14,913
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	434		$	1,823
Accrued expenses		591			1,727
Deferred revenue, current portion		3,010			6,343
Current liabilities of discontinued operations		-			1,359
Total current liabilities		4,035			11,252
Non-current liabilities of discontinued operations		-			597
Commitments and contingencies (See Note 4)		-			-
Total liabilities		4,035			11,849
Stockholders’ equity:
Convertible preferred stock, $0.001 par value, 25,000,000 shares authorized, 2,591,257 and 2,791,257 shares issued and outstanding, respectively		3			3
Common stock, $0.001 par value, 75,000,000 shares authorized, 24,509,435 and 24,182,524 shares issued and outstanding, respectively		25			24
Additional paid-in capital		239,497			238,882
Accumulated other comprehensive loss		-			(90	)
Accumulated deficit		(236,021	)		(235,755	)
Total stockholders’ equity		3,504			3,064
Total liabilities and stockholders’ equity	$	7,539		$	14,913

See accompanying notes to the condensed consolidated financial statements.

3

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

(In thousands, except share and per share data)

	Three Months Ended						Six Months Ended
	April 30,						April 30,
	2016			2015			2016			2015
Revenue:
IP license, royalty and other revenue	$	210		$	190		$	420		$	392
Cost of revenue:
IP license, royalty and other cost of revenue		49			16			100			53
Gross profit		161			174			320			339
Operating expenses:
General and administrative		1,356			2,638			3,705			4,066
Total operating expenses		1,356			2,638			3,705			4,066
Loss from operations		(1,195	)		(2,464	)		(3,385	)		(3,727	)
Other expense:
Interest expense		-			(99	)		-			(227	)
Amortization of debt discount and issuance costs		-			(179	)		-			(400	)
Other income		627			-			3,299			19
Loss from continuing operations		(568	)		(2,742	)		(86	)		(4,335	)
Discontinued operations:
Loss on discontinued operations		(1,194	)		(774	)		(1,812	)		(1,487	)
Gain on disposal of discontinued operations		1,771			-			1,771			-
Gain (loss) from discontinued operations		577			(774	)		(41	)		(1,487	)
Net income (loss)	$	9		$	(3,516	)	$	(127	)	$	(5,822	)
Dividends attributable to preferred stock	$	(78	)	$	(72	)	$	(129	)	$	(156	)
Net loss available to common stockholders, basic and diluted	$	(69	)	$	(3,588	)	$	(256	)	$	(5,978	)
Earnings (loss) per share, basic and diluted:
Discontinued operations	$	0.02		$	(0.04	)	$	(0.00	)	$	(0.08	)
Continuing operations	$	(0.02	)	$	(0.14	)	$	(0.00	)	$	(0.25	)
Available to common stockholder	$	(0.00	)	$	(0.19	)	$	(0.01	)	$	(0.34	)
Weighted average number of common shares outstanding, basic and diluted		24,784,822			19,286,525			24,534,672			17,584,841

See accompanying notes to the condensed consolidated financial statements.

4

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(unaudited)

(In thousands)

	Three Months Ended					Six Months Ended
	April 30,					April 30,
	2016		2015			2016			2015
Net income (loss)	$	9	$	(3,516	)	$	(127	)	$	(5,822	)
Other comprehensive income (loss):
Foreign currency translation adjustments		98		(11	)		90			(19	)
Comprehensive income (loss)	$	107	$	(3,527	)	$	(37	)	$	(5,841	)

See accompanying notes to the condensed consolidated financial statements.

5

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

(In thousands) 

	Six Months Ended
	April 30,
	2016			2015
Cash flows from operating activities:
Net loss	$	(127	)	$	(5,822	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation from discontinued operations		69			220
Gain on sale of discontinued operations		(919	)		-
Amortization of debt discount		-			400
Stock-based compensation		451			536
Provision for doubtful accounts receivable		(1	)		67
Changes in assets and liabilities:
Accounts receivable		630			468
Inventory		53			(167	)
Prepaid expenses and other assets		48			147
Accounts payable		(1,279	)		(80	)
Accrued expenses		(735	)		316
Accrued warranty costs		-			-
Deferred revenue		(4,559	)		175
Net cash used in operating activities		(6,369	)		(3,740	)
Cash flows from investing activities:
Purchase of property and equipment from discontinued operations		(28	)		(146	)
Proceeds from sale of discontinued operations		852			-
Net cash provided by (used in) investing activities		824			(146	)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of expenses		-			6,013
Repayment of debt		-			(1,973	)
Net cash provided by financing activities		-			4,040
Effect of foreign exchange rate on cash and cash equivalents		(131	)		(50	)
Change in cash and cash equivalents		(5,676	)		104
Cash, cash equivalents, and restricted cash beginning of period		11,792			4,946
Cash, cash equivalents, and restricted cash end of period	$	6,116		$	5,050
Supplemental disclosure of cash flow information:
Cash paid for interest	$	-		$	227
Cash paid for income taxes	$	2		$	1
Supplemental disclosure of non cash financing activities:
Conversion of preferred stock to common stock	$	302		$	418
Common stock dividends issued to preferred shareholders	$	139		$	169
Warrants issued with private placement stock	$	-		$	1,893
Lease incentive received, non-cash addition to fixed assets	$	-		$	243

See accompanying notes to the consolidated financial statements.

6

1. ORGANIZATION AND BASIS OF PRESENTATION

The accompanying consolidated financial statements include the accounts of Crossroads Systems, Inc. and its wholly-owned subsidiaries (“Crossroads” or the “Company”).   Headquartered in Austin, Texas, Crossroads, a Delaware corporation, is an intellectual property licensing company. Founded in 1996 as a product solutions company, Crossroads created some of the storage industry’s most fundamental patents and has licensed patents to more than 50 companies since 2000.

Principles of Consolidation and presentation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation.

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has accumulated significant losses as it has been developing its current and next generation products. The Company believes that cash flow from operations, customer reimbursed expenses, and proceeds from the sale of common and preferred stock will be sufficient to fund the anticipated operations for the next 12 months.  These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern for a reasonable period of time.

The investment in KIP CR P1 LP (which we refer to as the “partnership”), of which the Company is a limited partner and of which an affiliate of Fortress Investment Group LLC (“Fortress”) is the general partner, is accounted for using the equity method. The partnership holds the Company’s non’972 patent portfolio. The current investment balance is nominal at April 30, 2016.

Use of Estimates

The preparation of the consolidated financial statements in conformity with generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates, and such differences may be material to the consolidated financial statements.

Reclassification

Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassification includes assets, liabilities, and certain expenses in sales and marketing, research and development, and general and administrative related to discontinued operations. The amounts for the prior periods have been reclassified to be consistent with the current period presentation and have no impact on previously reported financials.

Cash, Cash Equivalents, and Restricted Cash

Cash, cash equivalents, and restricted cash consist of cash on deposit and highly liquid investments with original maturities of 90 days or less at date of purchase. While the Company’s cash and cash equivalents are on deposit with high quality FDIC and Association of German Banks insured financial institutions, at times such deposits exceed insured limits. As of April 30, 2016, total uninsured deposits were $5.8 million. The Company has not experienced any losses in such accounts.

Restricted cash amounted to $3.1 million. The balance consists of $2.9 million in cash held from the sale of a portion of the Company’s IP revenue stream, and $0.2 million in connection with a letter of credit on the lease of the Company headquarters.

7

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

IP Revenue Stream Sale

On October 30, 2015, the Company entered into an agreement with TQ Zeta LLC, an affiliate of Techquity, and Intrepidus Holdings LLC (collectively, “Techquity”), in which Techquity will share in the revenue generated from the ’972 patent litigation. For consideration of $10.0 million received by the Company, Techquity received the rights to 52% of the first $20 million in licenses, settlements or other awards related to the ’972 patents, 40% of the amounts between $20 and $100 million, and 12% of all amounts above $100 million in aggregate licensing, settlements or other awards. Proceeds from the TQ Zeta agreement are restricted to approved legal expenditures as defined in the agreement. During the three and six months ended April 30, 2016, the Company recognized $0.6 and $3.3 million in other income, respectively, $2.9 million is held in deferred revenue and restricted cash. Included in the amount recognized as revenue during the three and six months ended April 30, 2016 is $0.2 million recorded in liabilities, reducing restricted cash. The Company will recognize other income from this transaction as the authorized expenditures are made with the unspent balance being reflected as deferred revenue.

Contracts to Modify or Customize Products

The Company has entered into contracts with certain customers to significantly modify or customize products. In accounting for such arrangements, we first look to the guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 985-605, Software - Revenue Recognition (“ASC 985-605”), and then ASC Subtopic 605-25, Revenue Recognition – Multiple-Element Arrangements, to determine the appropriate accounting elements in the arrangement.  The Company then considers the appropriate recognition model for each accounting element based on the nature of the element and apply the guidance in ASC Subtopic 605-35, Revenue Recognition – Construction-Type and Production-Type Contracts, ASC Subtopic 985-60, ASC Subtopic 605-15, Revenue Recognition – Products, or ASC Subtopic 605-20, Revenue Recognition – Services, as applicable.  Amounts allocated to the modification/customization service element are evaluated for classification in the consolidated statement of operations as either revenue or reduction of research and development expense based on the following considerations: whether and in what circumstances the consideration received is refundable, ownership of the final product and intellectual property rights to develop the product, and exclusivity of the final product.

Computation of Net Loss Per Share

Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share is computed by giving effect to all dilutive potential common shares that were outstanding during the period. Basic earnings per share excludes the dilutive effect of common stock equivalents such as stock options and warrants, while earnings per share, assuming dilution, includes such dilutive effects. Future weighted-average shares outstanding calculations will be impacted by the following factors, among others: (i) the ongoing issuance of common stock associated with stock option and warrant exercises; (ii) any fluctuations in the Company’s stock price, which could cause changes in the number of common stock equivalents included in the earnings per share, assuming dilution computation; and (iii) the issuance of common stock to effect business combinations should the Company enter into such transactions.

The Company has excluded all outstanding common stock equivalents from the calculation of diluted net loss per share because all such common stock equivalents are antidilutive for all periods presented. The total number of common stock equivalents excluded from the diluted net loss per common share calculation was 13,776,052 and 13,411,599 for the six months ended April 30, 2016 and 2015, respectively. The dilutive common stock equivalents for the six months ended April 30, 2016 include warrants to purchase 7,375,327 shares of common stock, 2,591,257 shares of preferred stock, which are excluded until converted to common shares (Note 6), and stock options to purchase 3,809,468 shares of common stock.

Net loss available to common stockholders is calculated by deducting from net income, preferred dividends paid and accrued of $78,000 and $129,000 for the three and six months ended April 30, 2016, respectively.

Recently Issued Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) amended the existing accounting standards for revenue recognition. The amendments are based on the principle that revenue should be recognized in accordance to the transfer of promised goods or services to customers, reflecting the amount of consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB issued an accounting standard update for a one-year deferral of the effective date, with an option of applying the standard on the original effective date, which for Crossroads is the first quarter of fiscal 2018. In accordance with this deferral, the Company is required to adopt these amendments in the first quarter of fiscal 2019. The amendments may be applied retrospectively to each prior period presented or retrospectively with the cumulative effect recognized as of the date of initial application. The Company is continuing to evaluate the impact of these amendments and the transition alternatives on its consolidated financial statements and disclosures.

8

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

The Company has implemented all new accounting pronouncements that are in effect and that may impact its consolidated financial statements. The Company does not believe that there are any new accounting pronouncements that have been issued that might have a material impact on its consolidated financial position or results of operations.

2. FAIR VALUE MEASUREMENT

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measurements, a three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies, is applied as follows:

Level 1 – Valuations based on quoted prices for identical assets and liabilities in active markets.

Level 2 –  Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data.

Level 3 – Valuations based on unobservable inputs reflecting management’s assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.

As of April 30, 2016, the fair value of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximates book value due to the short maturity of these instruments. Based upon borrowing rates currently available to the Company for loans with similar terms, the carrying value of its debt obligations approximates fair value. As of April 30, 2016 and October 31, 2015, the Company held no investments.

3. ACCRUED EXPENSES AND DEFERRED REVENUE

Accrued expenses consist of the following (in thousands):

	April 30,		October 31,
	2016		2015
	(unaudited)
Payroll related	$	162	$	837
Professional services		340		657
Deferred rent		-		184
Warranty reserve		-		5
Other		89		44
	$	591	$	1,727

Included in payroll related accrued expenses as of April 30, 2016 and October 31, 2015 was $0.1 and $0.4 million, respectively, related to bonus compensation.  

9

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Deferred revenue, current portion, consists of the following (in thousands):

	April 30,		October 31,
	2016		2015
	(unaudited)
License	$	104	$	135
Deferred revenue stream sale		2,906		6,208
	$	3,010	$	6,343

Deferred revenue stream sale consists of the remaining amount of consideration received from the sale of a portion of the Company’s IP revenue stream. The deferred revenue will be recognized upon the expenditure of approved legal costs related to the ongoing IP litigation described in Note 4.

4. COMMITMENTS AND CONTINGENCIES

Leases

In accordance with the terms of the March 22, 2016 sale of our product division, the Company’s office space and equipment lease obligations have been assigned to the purchaser.

Intellectual Property Litigation

The Company has a number of ongoing lawsuits and related proceedings as described below. In discussing these patent litigation proceedings, the following terms will be used:

A “Markman hearing” in a patent infringement case is a pre-trial hearing in U.S. District Court, in which the Court hears arguments regarding the meanings of key words used in a disputed patent claim. The outcome of a Markman hearing can play a significant role in whether findings of infringement and validity are made by the Court or by the jury at trial. Depending on the Court, a ruling could be received quickly or could take months after the Markman hearing.

An “Inter Partes Review,” or “IPR,” is a post-grant review of an issued patent in which the petitioner attempts to challenge the validity of a patent on certain grounds (e.g. novelty and obviousness). If successful during inter partes review, a petitioner could potentially invalidate some or all of the claims in the patents asserted against that petitioner in related litigation, and an adverse ruling in any of these proceedings would result in invalidation or other limitations on the Company’s patent rights. Inter partes review, if granted, is typically a twelve- to eighteen-month process from institution.

Crossroads v. Dot Hill

The Company filed a lawsuit on September 11, 2013 against Dot Hill Systems Corp. (“Dot Hill”) styled Crossroads Systems, Inc. v. Dot Hill Systems Corp., Civil Action No. 1:13-CV-800-SS alleging patent infringement of U.S. Patent No. 6,425,035 (the “035 patent”) and breach of the Amended Settlement and License Agreement dated June 27, 2006 between Crossroads and Dot Hill. The action is pending. The Markman hearing was conducted October 6-7, 2014. Dot Hill moved to join two existing IPR proceedings previously filed against Crossroads by other defendants (one filed by NetApp/Oracle/Huawei and one filed by Cisco/Quantum, each as defined below) and to stay the pending litigation based on those IPR proceedings. On June 16, 2015, Judge Sparks entered the Markman order (the “Markman Order”) construing the claims in a manner favorable to Crossroads and issued an order staying the case pending resolution of the IPR proceedings. The United States Patent and Trademark Office (the “U.S. Patent Office”) issued rulings in both of the IPR proceedings that Dot Hill had joined, ruling in one that the ’035 Patent is not unpatentable in view of the prior art raised and in the other that the ’035 Patent is unpatenable in view of different prior art. Crossroads believes the ruling of unpatentability was in error and has filed an appeal of that ruling with the Federal Circuit Court of Appeals. That appeal is on-going. If the patent asserted against Dot Hill is found partially or entirely invalid at the conclusion of the IPR proceedings, including appeal, Crossroads might be adversely impacted in the litigation proceeding against Dot Hill, including potentially losing the ability to continue with its claims of infringement. In May 2016, Crossroads filed a motion to lift the stay for limited purposes regarding Dot Hill’s failure to pay certain royalties. A hearing took place June 2, 2016 on this motion and Crossroads anticipates the Court will decide that motion within the next two months.

10

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Dot Hill owes the Company approximately $1.0 million at April 30, 2016 related to an agreement between the companies. The Company believes these amounts have been earned and collectability is probable at April 30, 2016.

Crossroads v. Oracle, Huawei, Cisco, NetApp, and Quantum

These related cases were filed on October 7, 2013, November 26, 2013, and February 18, 2014 in the United States District Court for the Western District of Texas alleging infringement by these parties of one or more patents in the ’972 patent family. The asserted patents (6,425,035, 7,934,041, 7,987,311 and 7,051,147) were subject to a re-examination of the patents conducted in 2005-2006 by the U.S. Patent Office or were issued after the re-examination. On May 7, 2014, these cases and the Dot Hill case were consolidated for purposes of discovery and a Markman hearing occurred on October 6 and 7, 2014. On June 16, 2015, Judge Sparks entered the Markman Order construing the claims in a manner favorable to Crossroads and entered an order staying these actions in light of the IPR proceedings.

During the time Crossroads was pursuing the potential infringers of the ’972 patent family, the Company gave companies with potentially infringing products the opportunity to license the Company’s proprietary technology. For example, NetApp was first given notice of potential infringement in 2004. Cisco was first given notice of potential infringement in 2002. Quantum has been on notice of its potential infringement since 2006. Oracle acquired several companies that were given notice of potential infringement at least as early as 2009 and Oracle itself has been on notice since then. Despite repeated attempts by Crossroads throughout the years to negotiate licenses to the ’972 patent family, these companies refused and left Crossroads with no alternatives but litigation. Crossroads believes these companies (and companies they have acquired) have been illegally using Crossroads’ proprietary technology and that the potential compensatory damages could be in excess of $200 million, which does not include enhanced damages or attorney fees. While the uncertainties and expense of litigation are great and the Company can provide no guarantees of success, the Company believes the infringement by most of these companies has been prolonged and potentially willful.

In response to the lawsuits brought by Crossroads, collectively these defendants filed nineteen inter partes review petitions with the U.S. Patent Office to challenge the validity of the patents asserted by the Company in these lawsuits. The U.S. Patent Office instituted review of six of the petitions, granted joinder in four of the petitions and denied review of the remaining nine petitions. The first of the petitions were filed only months after Crossroads filed lawsuits against these parties and years after they were made aware of their potential infringement. Crossroads continues to believe it has meritorious factual and legal defenses to the challenges presented in these petitions and will vigorously defend the validity of the patents. The U.S. Patent Office issued rulings in the IPR proceedings, ruling in one that the ’035 Patent is not unpatentable in view of the prior art raised and ruling in the others that the ’035 Patent and Patent No. 7,051,147 (the “’147 Patent”) are unpatenable in view of different prior art. Crossroads believes the rulings of unpatentability were in error and has appealed these rulings to the Federal Circuit Court of Appeals. Those appeals are on-going. If these patents, which have been asserted against Oracle, Cisco, NetApp, and Quantum, are found partially or entirely invalid at the conclusion of these IPR proceedings, including appeal, Crossroads might be adversely impacted in the litigation proceedings against these companies, including potentially losing the ability to continue with its claims of infringement.

The Company filed a lawsuit on October 7, 2013 against Oracle Corporation (“Oracle”) alleging infringement of U.S. Patent Nos. 6,425,035, 7,051,147 and 7,934,041 (the case is styled Crossroads Systems, Inc. v. Oracle Corporation; Civil Action No. 1:13-cv-0895-SS (W.D. Tex., Austin Division)). The action is pending. The Markman hearing was conducted October 6-7, 2014 and on June 16, 2015, Judge Sparks entered the Markman Order construing the claims in a manner favorable to Crossroads. Oracle filed nine petitions for IPR at the U.S. Patent Office challenging the validity of each of the patents Crossroads asserted in the lawsuit against Oracle. The U.S. Patent Office granted six of those petitions. Based on the IPRs, Oracle filed a motion to stay the litigation pending the outcome of the IPR proceedings, which was granted by the Court. The U.S. Patent Office issued rulings in the IPR proceedings involving Oracle, ruling in one that the ’035 Patent is not unpatentable over the prior art and ruling in the other five that the ’035 Patent and ’147 Patent are unpatenable in view of different prior art. Crossroads believes the rulings of unpatentability were in error and has appealed these rulings to the Federal Circuit Court of Appeals. Those appeals are on-going. If the patents are found partially or entirely invalid during the IPR proceedings, including appeal, Crossroads might be adversely impacted in the litigation proceeding against Oracle, including potentially losing the ability to continue with its claims of infringement.

11

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

The Company filed a lawsuit on February 18, 2014 against Cisco Systems, Inc. (“Cisco”) alleging infringement of U.S. Patent Nos. 6,425,035 and 7,934,041 (the case is styled Crossroads Systems, Inc. v. Cisco Systems, Inc.; Civil Action No. 1:14-cv-00148-SS (W.D. Tex., Austin Division)). The action is pending. The Markman hearing was conducted October 6-7, 2014 and on June 16, 2015, Judge Sparks entered the Markman Order construing the claims in a manner favorable to Crossroads. Cisco is a party to three petitions for IPR filed at the U.S. Patent Office challenging the validity of each of the patents Crossroads asserted in the lawsuit against Cisco. The U.S. Patent Office granted those petitions. Based on the IPRs, Cisco filed a motion to stay the litigation pending the outcome of the IPR proceedings, which was granted by the Court. The U.S. Patent Office issued rulings in the IPR proceedings involving Cisco, ruling that the ’035 Patent and ’147 Patents are unpatentable in view of the cited prior art. Crossroads believes the rulings of unpatentability were in error and has appealed these rulings to the Federal Circuit Court of Appeals. Those appeals are on-going. If the patents are found partially or entirely invalid during the IPR proceedings, including appeal, Crossroads might be adversely impacted in the litigation proceeding against Cisco, including potentially losing the ability to continue with its claims of infringement.

The Company filed a lawsuit on February 18, 2014 against NetApp, Inc. (“NetApp”) alleging infringement of U.S. Patent Nos. 6,425,035, 7,934,041, 7,987,311 and 7,051,147 (the case is styled Crossroads Systems, Inc. v. Net App, Inc.; Civil Action No. 1:14-cv-00149-SS (W.D. Tex., Austin Division)). The action is pending. The Markman hearing was conducted October 6-7, 2014 and on June 16, 2015, Judge Sparks entered the Markman Order construing the claims in a manner favorable to Crossroads. NetApp filed seven petitions for IPR filed at the U.S. Patent Office challenging the validity of each of the patents Crossroads asserted in the lawsuit against NetApp. The U.S. Patent Office granted three of those petitions. Based on the IPRs, NetApp filed a motion to stay the litigation pending the outcome of the IPR proceedings, which was granted by the Court. The U.S. Patent Office issued rulings in the IPR proceedings involving NetApp, ruling in one that the ’035 Patent is not unpatentable over the prior art and ruling in the others that the ’147 Patent is unpatenable in view of different prior art. Crossroads believes the rulings of unpatentability were in error and has appealed these rulings to the Federal Circuit Court of Appeals. Those appeals are on-going. If the patents are found partially or entirely invalid during the IPR proceedings, including appeal, Crossroads might be adversely impacted in the litigation proceeding against NetApp, including potentially losing the ability to continue with its claims of infringement.

The Company filed a lawsuit on February 18, 2014 against Quantum Corporation (“Quantum”) alleging infringement of U.S. Patent Nos. 6,425,035 and 7,934,041 (the case is styled Crossroads Systems, Inc. v. Quantum Corporation; Civil Action No. 1:14-cv-00150-SS (W.D. Tex., Austin Division)). The action is pending. The Markman hearing was conducted October 6-7, 2014 and on June 16, 2015, Judge Sparks entered the Markman Order construing the claims in a manner favorable to Crossroads. Quantum filed three petitions for IPR filed at the U.S. Patent Office challenging the validity of each of the patents Crossroads asserted in the lawsuit against Quantum. The U.S. Patent Office granted those petitions. Based on the IPRs, Quantum filed a motion to stay the litigation pending the outcome of the IPR proceedings, which was granted by the Court. The U.S. Patent Office issued rulings in the three IPR proceedings involving Quantum, ruling that the ’035 Patent and ’147 Patents are unpatentable in view of the cited prior art. Crossroads believes the rulings of unpatenability were in error and has appealed those rulings to the Federal Circuit Court of Appeals. Those appeals are on-going. If the patents are found partially or entirely invalid during the IPR proceedings, including appeal, Crossroads might be adversely impacted in the litigation proceeding against Quantum, including potentially losing the ability to continue with its claims of infringement.

Dot Hill v. Crossroads

On June 29, 2015, Dot Hill filed a lawsuit in the U.S. District Court for the District of Colorado alleging that the Company’s StrongBox product infringed a patent owned by Dot Hill. On April 22, 2016 the parties entered into a settlement agreement resolving the action and on May 5, 2016, the case was dismissed.

12

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

5. DISCONTINUED OPERATIONS

On March 22, 2016, the Company entered into a Purchase and Assignment Agreement (the “Purchase Agreement”) with StrongBox Data Solutions, Inc. (“SDSI”), a Quebec corporation.

Under the Purchase Agreement, the Company sold and transferred all of the assets related to the Company’s product and support services division (the “Business”), including the Company’s StrongBox and SPHiNX storage solutions, to SDSI. SDSI also assumed certain liabilities of the Company related to the Company’s product business, and absorbed the majority of Crossroads’ employees. As consideration under the Purchase Agreement, SDSI paid the Company net proceeds equal to $1.9 million in cash on the closing date. Consideration of $1.0 million was paid to the holders of the Company’s Series F Preferred Stock in exchange for a vote for approval of the divestiture. The Board of Directors approved this payment, which has been reflected as a cost to sell the business.

The assets and liabilities transferred for consideration received were (in thousands, at book value, unaudited):

Cash Received	$	1,852
Cash paid to Series F Convertible Preferred shareholders		(1,000	)
Net cash received		852
Fixed Assets		(499	)
Inventory		(386	)
Other Comprehensive Income		(110	)
Expenses incurred		(79	)
Deferred Revenue		1,795
Other Assets and Liabilities		198
Net gain on sale of discontinued operations	$	1,771

Certain items were reclassified as part of discontinued operations for comparative purposes. The table below presents the amounts by balance sheet classification (in thousands):

	April 30,		October 31,
	2016		2015
Assets		(unaudited)		(unaudited)
Current assets:
Accounts receivable, net	$	-	$	976
Inventories		-		437
Prepaids expenses, and other current assets		-		131
Total current assets		-		1,544
Property and equipment, net		-		533
Other assets		-		30
Total assets	$	-	$	2,107
Liabilities
Current liabilities:
Accounts payable		-		400
Accrued expenses		-		68
Deferred revenue		-		891
Total current liabilities		-		1,359
Long term deferred revenue		-		596
Total liabilities	$	-	$	1,955

13

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

The amounts in the statement of operations that are part of the discontinued operations are summarized in the following table (in thousands):

	Three Months Ended						Six Months Ended
	April 30,						April 30,
	2016			2015			2016			2015
Revenue:		(unaudited)			(unaudited)			(unaudited)			(unaudited)
Product	$	-		$	584		$	859		$	1,446
IP License, royalty and other		(63	)		946			923			2,053
Total revenue		(63	)		1,530			1,782			3,499
Cost of revenue:
Product		-			220			309			502
IP License, royalty and other		41			176			275			433
Total cost of revenue		41			396			584			935
Gross profit		(104	)		1,134			1,198			2,564
Operating expenses:
Sales and marketing		452			829			1,275			1,700
Research and development		638			1,079			1,735			2,351
Total operating expenses		1,090			1,908			3,010			4,051
(Loss) income from discontinued operations	$	(1,194	)	$	(774	)	$	(1,812	)	$	(1,487	)

14

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

6. STOCKHOLDERS’ EQUITY

2013 Private Placement

On March 22, 2013, the Company entered into a securities purchase agreement with certain accredited investors for the issuance and sale in a private placement of 4,231,154 units at a purchase price of $2.0625 per unit, valued at $8.6 million, for net proceeds of approximately $7.9 million after related expenses. Each unit consists of one share of cumulative 5.0% Series F convertible preferred stock (“Series F Preferred Stock”), par value $0.001 per share, and a warrant to purchase one-half of a share of common stock per share of Series F Preferred Stock purchased, at an exercise price of $2.00 per whole share, subject to certain adjustments, resulting in the issuance of warrants to purchase an additional 2,282,754 shares of common stock with an exercise price of $2.00 per share. In connection with the 2015 Common Stock Rights Offering, defined below, an additional 0.2019 warrants were granted for every outstanding warrant on August 31, 2015. As of April 30, 2016, there were 2,439,585 warrants outstanding. The Series F Preferred Stock ranks senior to the common stock and each other class or series of the Company’s capital stock, whether common, preferred or otherwise, with respect to distributions of dividends and distributions upon liquidation, dissolution or winding up of the Company. The warrants were initially valued using the Black-Scholes pricing model at approximately $2,284,000.  The relative fair value of these warrants totaling $1,543,000 was initially allocated to additional paid in capital.  The Black-Scholes inputs used were:  expected dividend rate of 0 %, expected volatility of 63%, risk free interest rate of 0.82%, and expected term of 5 years.  This valuation resulted in a beneficial conversion feature on the Series F Preferred Stock of approximately $1,090,000, which was recorded as a deemed dividend.  Fees in the amount of $0.7 million relating to the stock placement were netted against proceeds. The warrants were exercisable immediately upon issue, and expire March 22, 2018.  During the six months ended April 30, 2015, the Company issued 67,781 dividend common shares valued at approximately $169,000. During the six months ended April 30, 2016, the Company issued a dividend of 126,911 common shares valued at approximately $302,000. Accrued and unpaid dividends were valued at approximately $88,000 as of April 30, 2016.

The Series F Preferred Stock has the rights, qualifications, limitations and restrictions set forth in the Certificate of Designation (the “Certificate of Designation”) filed with the Secretary of State of the State of Delaware on March 28, 2013. The Certificate of Designation authorizes issuance of up to 4,500,000 shares of Series F Preferred Stock, with 3,750,000 shares designated as “Sub-Series F-1” and 750,000 shares designated as “Sub-Series F-2.” The right of holders of Series F Preferred Stock to convert the Series F Preferred Stock is subject to a 9.99% beneficial ownership limitation for holders of Sub-Series F-1 and a 4.99% beneficial ownership limitation for holders of Sub-Series F-2. Such beneficial ownership limitations may be increased or decreased by a holder of Sub-Series F-1 to any percentage not in excess of 19.99% after providing notice of such increase or decrease to the Company. For as long as at least 90% of the aggregate number of shares of Sub-Series F-1 issued on the original issue date are outstanding, the holders of such Sub-Series F-1, voting as a single class, will be entitled to elect two directors of the Company. If less than 90%, but at least 20%, of such shares of Sub-Series F-1 are outstanding, such holders, voting as a single class, will be entitled to elect one director of the Company. As of the date hereof, less than 78% of the aggregate number of shares of Sub-Series F-1 are outstanding, as the remainder have been voluntarily converted into common stock at the option of the holders. Therefore, the holders of the Sub-Series F-1 shares are entitled to elect one director to the Board of Directors. The holders of Sub-Series F-2 will not be entitled to vote on the directors elected by the holders of Sub-Series F-1. The holders of shares of the Series F Preferred Stock are entitled to a liquidation preference equal to the original issuance price plus any unpaid dividends.

The Certificate of Designation contains customary anti-dilution protection for proportional adjustments (e.g. stock splits). The Series F Preferred Stock previously included an anti-dilution provision that would adjust the conversion price of the Series F Preferred Stock to the issue price of any equity securities the Company issued at a price less than $2.0625 per share, subject to certain exceptions. This type of provision is commonly referred to as a “full-ratchet” anti-dilution provision.    

Upon approval of the full ratchet anti-dilution provisions on June 21, 2013, the warrants were reclassified as a derivative liability and recorded at fair value. This created a scenario for which the shares of Series F Preferred Stock were potentially convertible into more shares of common stock than authorized. Therefore, the Series F Preferred Stock was classified in temporary equity. Upon the expiration of the full ratchet anti-dilution provisions in March 2014, the Company reclassified the Series F Preferred Stock and warrants to permanent stockholders’ equity following the stockholders vote.

15

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

During the six months ended April 30, 2016, 200,000 shares of Series F Preferred Stock were converted to common shares.

Dividends on the Series F Preferred Stock accrue at an annual rate of 5.0% of the original issue price and are payable on a semi-annual basis. The Series F Preferred Stock ranks senior to the common stock and each other class or series of the Company’s capital stock, whether common, preferred or otherwise, with respect to distributions of dividends and distributions upon liquidation, dissolution or winding up of the Company. The Company may elect to satisfy the obligation to pay semi-annual dividends in cash, by distribution of common stock or a combination thereof, in the Company’s discretion.

2013 Fortress Credit Agreement

On July 22, 2013 the Company issued warrants to purchase 1,454,545 shares of its common stock to Fortress at $2.0625 per share (the “Fortress Warrants”). To derive an estimate of the fair value of these warrants, the Company utilized a dynamic Black-Scholes formula that computes the impact of share dilution upon the exercise of the warrant shares. This process relies upon inputs such as shares outstanding, estimated stock prices, strike price and volatility assumptions to dynamically adjust the payoff of the warrants in the presence of the dilution effect.   The Fortress Warrants were recorded at a fair value of $1,374,000 or $1.0625 per underlying warrant share. In connection with the Offering (as defined below), an additional 0.2019 warrants were granted for every outstanding warrant on August 31, 2015, with the strike price remaining at $2.0625. As of April 30, 2016, there were 1,748,218 warrants outstanding.

The Fortress Warrants will expire on the seventh anniversary of the effective date of the Fortress transactions.

2014 Private Placement

On March 31, 2014, the Company sold 1,986,622 units at $2.2565 per unit for gross proceeds to the Company of $4.5 million. Each unit consists of one share of common stock and a warrant to purchase one-half of a share of common stock.  The warrants to purchase 993,311 shares of common stock have a weighted average exercise price of $2.45 per share.  Fees in the amount of $0.2 million relating to the stock placement were netted against proceeds.  The warrants were valued at $1.1 million using the Black-Scholes model.  The Black-Scholes inputs used were:  expected dividend rate of 0%, expected volatility of 74%, risk free interest rate of 1.64%, and expected term of 2.5 years.  The warrants were exercisable upon the six-month anniversary of issue, and expire March 31, 2019. In connection with the Offering, an additional 0.2019 warrants were granted for every outstanding warrant on August 31, 2015, with the strike price remaining at $2.45. As of April 30, 2016, there were 1,193,860 warrants outstanding. 

2015 Common Stock Offering

On January 27, 2015, the Company sold 3,071,739 units at $2.30 per unit for gross proceeds to the Company of $7.1 million. Each unit consists of one share of common stock and a warrant to purchase one-half of a share of common stock.  The warrants to purchase 1,658,760 shares of common stock have an exercise price of $2.76 per share.   Fees in the amount of $1.1 million relating to the stock placement were netted against proceeds.  The warrants were valued at $1.9 million using the Black-Scholes model.  The Black-Scholes inputs used were:  expected dividend rate of 0%, expected volatility of 75%, risk free interest rate of 1.55%, and expected term of 4.0 years.  The warrants will be exercisable upon the six-month anniversary of issue, and expire January 31, 2020. In connection with the Offering an additional 0.2019 warrants were granted for every outstanding warrant on August 31, 2015, with the strike price remaining at $2.76. As of April 30, 2016, there were 1,993,664 warrants outstanding. 

2015 Common Stock Rights Offering

On July 28, 2015, the Company completed a subscription rights offering for shares of the Company’s common stock (the “Rights Offering”). Under the terms of the Rights Offering, the Company distributed to its common and preferred stock holders one subscription right for each share of the Company’s common or preferred stock owned as of the record date, which entitled the holder to purchase 0.50 shares of common stock, at the subscription price of $1.25 per share, subject to certain protection mechanics in place to preserve the Company’s ability to utilize its net operating loss carryforwards (“NOLs”).

16

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

The Company accepted subscriptions for 3,933,879 shares, resulting in aggregate gross proceeds of approximately $4.9 million. Expenses incurred to complete the Rights Offering amounted to approximately $0.4 million.

The Company has the following common stock warrants outstanding at April 30, 2016:

Warrant Transaction	Warrants Outstanding		Weighted Average Exercise Price
2013 Private Placement		2,439,585	$	2.00
2013 Fortress Credit Agreement		1,748,218	$	2.06
2014 Private Placement		1,193,860	$	2.45
2015 Common Stock Offering		1,993,664	$	2.76
Total Warrants		7,375,327

7. STOCK OPTIONS AND STOCK BASED COMPENSATION

The Company has a stock-based compensation plan available to grant incentive stock options, non-qualified stock options and restricted stock to employees and non-employee members of the Board of Directors and advisors.

The Company’s 2010 Stock Incentive Plan (the “2010 Plan”) succeeded the 1999 Stock Option/Stock Issuance Plan (the “1999 Plan”).  As of April 30, 2016, options to purchase 285,683 shares of common stock were outstanding under the 1999 Plan, and no further grants can be made under the 1999 Plan.

The 2010 Plan was approved by the Board of Directors on May 26, 2010 and became effective on August 13, 2010, upon approval by stockholders, and was subsequently amended by the Board of Directors on March 12, 2015 and approved by stockholders on April 24, 2015.  A maximum of 5,250,000 shares of Crossroads common stock may be awarded.  As of April 30, 2016, options to purchase 5,304,943 shares of common stock were granted from the 2010 Plan, of which 3,523,785 were outstanding. During the six months ended April 30, 2016 and 2015, 0 and 117,577 common stock shares were granted from the 2010 Plan, respectively.

As of April 30, 2016, options to purchase an aggregate of 3,809,468 shares of common stock were outstanding under the 1999 Plan and the 2010 Plan, of which 3,220,395 were vested. Under the 2010 Plan, 785,302 shares of common stock were available for future grants as of April 30, 2016.  The shares of common stock reserved for future grant are reduced by 526,741 options previously exercised under the 2010 Plan, and 414,172 shares of stock granted under the 2010 Plan.  The Compensation Committee of the Board of Directors determines the exercise price, term and other conditions applicable to each stock option granted under the 2010 Plan. The exercise price of stock options is set on the grant date and may not be less than the fair market value per share of the Company’s stock on that date (at market close). The 2010 Plan options generally become exercisable over a four-year period (vesting 25% after one year, the remaining 75% vesting quarterly thereafter) and expire after ten years. The majority of the employee incentive stock option grants vest on a schedule of 25% at the end of six months and 12.5% thereafter until fully vested. Stock option exercises are fulfilled with new shares of common stock.

17

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

The Company realized stock-based compensation expense for all awards issued under the Company’s stock plans in the following line items in the consolidated statements of operations:

	Six months ended April 30,
	2016		2015
General and administrative	$	348	$	332
Discontinued operations		103		204
Total stock-based compensation	$	451	$	536

The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model. Expected volatility is based on historical volatility of the Company’s common stock. The expected term represents an estimate of the time options are expected to remain outstanding based upon historical analysis. The risk-free rate for periods within the contractual life of the option is based on the U.S. treasury yield curve in effect at the time of grant. The variables used in the Black-Scholes calculation are listed below for the respective periods, no options were granted during the six months ended April 30, 2016:

	Six months ended April 30,
	2016		2015
Expected dividend yield		-		0	%
Expected volatility		-		75 - 76	%
Risk-free interest rate		-		1.4 - 1.6	%
Expected term (years)		-		4 - 5

The following table summarizes information about stock option activity for the six months ended April 30, 2016:  

	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value ($M)
Outstanding and expected to vest at October 31, 2015		4,111,896		$	1.86		7.26	$	0.2
Granted		-		$	-
Forfeited		(302,428	)	$	3.17
Exercised		-		$	-
Outstanding and expected to vest at April 30, 2016		3,809,468		$	1.75		4.14	$	-
Exercisable at April 30, 2016		3,220,395		$	1.77		3.71	$	-

The weighted average fair value per option granted during the six months ended April 30, 2016 and 2015 was $0 and $1.68, respectively. The total intrinsic value of options (which is the amount by which the stock price exceeded the exercise price of the options on the date of exercise) exercised during the six months ended April 30, 2016 and 2015 was $0 and $35,000, respectively. During the six months ended April 30, 2016 and 2015, the amount of cash received from the exercise of stock options was $0 and $49,000, respectively.

The Company granted no options to non-employees during the six months ended April 30, 2016 and 2015.

At April 30, 2016, there was approximately $0.4 million of total unrecognized compensation cost related to non-vested stock option awards which is expected to be recognized over a weighted-average period of 0.6 years. There were 202,904 and 469,092 options that became vested during the six months ended April 30, 2016 and 2015, respectively, with the total fair value of these awards of approximately $0.3 million and $0.7 million, respectively.

18

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

The following table shows information about outstanding stock options at April 30, 2016:

				Options Outstanding						Options Exercisable
						Weighted
						Average		Weighted				Weighted
Range of				Shares		Remaining		Average				Average
Exercise Prices				Outstanding		Contractual Term		Exercise Price		Shares		Exercise Price
$	-	$	1.01		415,005		2.59	$	0.91		415,005	$	0.91
$	1.03	$	1.23		142,486		6.96	$	1.06		85,950	$	1.04
$	1.28	$	1.28		540,900		7.56	$	1.28		540,900	$	1.28
$	1.30	$	1.34		522,013		3.34	$	1.32		275,513	$	1.30
$	1.41	$	1.70		144,421		2.77	$	1.47		94,846	$	1.50
$	1.75	$	1.75		981,752		1.29	$	1.75		981,752	$	1.75
$	1.76	$	2.13		466,819		7.47	$	2.06		335,802	$	2.04
$	2.28	$	3.73		430,107		5.42	$	2.77		324,662	$	2.93
$	3.95	$	4.99		163,879		2.25	$	4.10		163,879	$	4.10
$	5.99	$	5.99		2,086		5.25	$	5.99		2,086	$	5.99
$	-	$	5.99		3,809,468		4.14	$	1.75		3,220,395	$	1.77

8. EMPLOYEE BENEFITS

In 1996, the Company established the Crossroads Systems, Inc. 401(k) Savings Plan (the “Savings Plan”), which is a qualified plan under section 401(k) of the Internal Revenue Code.  All employees who have attained 18 years of age are eligible to enroll in the Savings Plan.   The Company may make matching contributions to those employees participating in the Savings Plan based upon Company productivity and profitability. Company contributions vest over a period of six years.  In October 2000, the Company adopted a new 401(k) Savings Plan that meets all of the criteria set forth above in the savings plan.  The Company made matching contributions of $82,000 and $93,000 during the six months ended April 30, 2016 and 2015, respectively.

9. RELATED PARTY TRANSACTIONS

2015 Private Placement

On January 27, 2015, the Company entered into placement agency agreements with certain accredited investors for the issuance and sale in a private placement (the “2015 Private Placement”) of an aggregate of 3,071,739 units, at a purchase price of $2.30 per unit for net aggregate proceeds of approximately $7.1 million before expenses. Each unit consisted of one share of common stock and warrants to purchase one-half of a share of common stock at an exercise price of $2.76 per whole share. Lone Star Value Investors, LP (“Lone Star Value LP”), controlled by Jeffrey E. Eberwein, Crossroads’ Chairman of the Board of Directors at the time, acquired 350,000 units in the placement for approximately $0.8 million.

2015 Common Stock Rights Offering

On July 29, 2015, the Company completed a Rights Offering for the Company’s common stock, accepting subscriptions for 3,933,879 shares of common stock at $1.25 per share, for aggregate gross proceeds of approximately $4.9 million. Lone Star Value LP, controlled by Jeffrey E. Eberwein, Crossroads’ Chairman of the Board of Directors at the time, acquired 1,537,907 shares in the Rights Offering for approximately $1.9 million pursuant to the terms of the Rights Offering.

Discontinued operations consideration paid

During the three months ended April 30, 2016 the Company’s Board of Directors approved a payment to the Series F Preferred Shareholders of the greater of 50% of the net proceeds from the sale of the business or $1.0 million. The sale of the business required a 70% approval of the Series F Preferred Shareholders. The $1.0 million payment was recognized as an expense of selling the business.

19

CROSSROADS SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

10. PREFERRED STOCK RIGHTS

On May 23, 2014, the Company’s Board of Directors adopted a tax benefit preservation plan (the “Plan”). The Plan is intended to diminish the risk that the Company’s ability to use NOLs to reduce future federal income tax obligations may become substantially limited due to an “ownership change,” as defined in Section 382 of the Internal Revenue Code. The Board of Directors authorized and declared a dividend distribution of one right for each outstanding share of common stock, par value $0.001 per share, and Series F Preferred Stock, par value $0.001 per share, of the Company to stockholders of record as of the close of business on June 4, 2014. Each right entitles the registered holder to purchase from the Company one one-thousandth of a share of Series G Participating Preferred Stock, par value $0.001 per share, of the Company at an exercise price of $14.00 per one one-thousandth of a share of Series G Participating Preferred Stock, subject to adjustment.

The rights will become exercisable following (i) the 10th business day (or such later date as may be determined by the Board of Directors) after the public announcement that an acquiring person has acquired beneficial ownership of 4.99% or more of the common stock (calculated pursuant to the Plan) or (ii) the 10th business day (or such later date as may be determined by the board) after a person or group announces a tender or exchange offer that would result in ownership by a person or group of 4.99% or more of the common stock (calculated pursuant to the Plan).

In addition, upon the occurrence of certain events, the exercise price of the rights would be adjusted and holders of the rights (other than rights owned by an acquiring person or group) would be entitled to purchase common stock at approximately half of market value. Given the potential adjustment of the exercise price of the rights, the rights could cause substantial dilution to a person or group that acquires 4.99% or more of the Company’s common stock on terms not approved by the Company’s Board of Directors.

No rights were exercisable at April 30, 2016. There is no impact to the Company’s financial results as a result of the adoption of the Plan for the six months ended April 30, 2016 or 2015. 

11. SUBSEQUENT EVENTS

On May 25, 2016, the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the outstanding shares of the Company’s common stock at a ratio of one-for-twenty at the Company’s annual meeting of stockholders. The Company anticipates the effective date of this stock split to be June 20, 2016.

20 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of the financial condition and results of our operations should be read in conjunction with the condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q and the audited consolidated financial statements and related notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended October 31, 2015. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those discussed below. Factors that could cause or contribute to such differences include, but are not limited to, those identified below, and those discussed in the section entitled “Risk Factors” included elsewhere in our filings with the Securities and Exchange Commission (the “SEC”).

Forward-Looking Statements

Various statements contained in or incorporated by reference into this quarterly report that express a belief, expectation, or intention, or that are not statements of historical fact, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). These forward-looking statements may include projections and estimates concerning capital expenditures, our liquidity and capital resources, the timing and success of specific projects, outcomes and effects of litigation, claims and disputes, elements of our business strategy and other statements concerning our operations, economic performance and financial condition. When used in this quarterly report, the words “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “may,” “continue,” “predict,” “potential,” “project” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. In particular, the factors discussed below and detailed in our Form 10-K for the year ended October 31, 2015, as well as those discussed in the section entitled “Risk Factors” included elsewhere in our filings with the SEC, could affect our actual results and cause our actual results to differ materially from expectations, estimates, or assumptions expressed in, forecasted in, or implied in such forward-looking statements.

Forward-looking statements may include statements about our:

· ability to implement our business strategy, including the ability to monetize intellectual property through licensing or sale;

· anticipated trends and challenges in our business and the markets in which we operate;

· expected future financial performance;

· expectations regarding our operating expenses;

· ability to generate revenues from patent licensing and enforcement activity through our arrangement with Fortress;

· ability to fully utilize the company’s net operating loss tax benefit;

· ability to protect our confidential information and intellectual property rights;

· ability to successfully identify and manage any potential acquisitions;

· ability to remediate any material weakness in our internal controls identified by our independent registered public accounting firm;

· ability to maintain or broaden our business relationships and develop new relationships with strategic alliances, suppliers, customers, distributors or otherwise;

· ability to recruit and retain qualified key personnel;

· ability to obtain additional financing; and

· ability to manage growth.

All forward-looking statements involve risks, assumptions and uncertainties. The occurrence of the events described, and the achievement of the expected results depends on many events, some or all of which are not predictable or within our control. Actual results may differ materially from expected results. These risks, assumptions and uncertainties are not necessarily all of the important factors that could cause actual results to differ materially from those expressed in any of our forward-looking statements. Other unknown or unpredictable factors also could harm our results. In light of these risks, uncertainties and assumptions, the forward-looking events might not occur.

21 

Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other things contemplated by the forward-looking statements will not occur. Forward-looking statements in this quarterly report are based on management’s beliefs and opinions at the time the statements are made. The forward-looking statements contained in this quarterly report are expressly qualified in their entirety by this cautionary statement. The forward-looking statements included in this Quarterly Report on Form 10-Q are made as of the date of this quarterly report and we undertake no obligation to publicly update or revise any forward-looking statements to reflect new information, future events or otherwise, except as required by applicable securities laws.

Overview

The following discussion and analysis of the financial condition and results of our operations should be read in conjunction with consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q.

Our Direction and Strategy

Since its inception in 1996, Crossroads has been a prolific creator of intellectual property. As pioneers in data storage, our engineers created some of the industry’s most important breakthroughs, many of which are still utilized today by technology leaders. The patents we authored are the result of investing heavily in research and development. This strategic focus resulted in Crossroads gaining unique and extensive knowledge of data storage and data management technologies. Therefore, protecting our proprietary technology is vital to our business strategy. More than 50 companies have licensed our technology since 2000 and Crossroads has been paid more than $61 million for the right to use our inventions. We believe there are additional companies who would benefit from a license to our technology.

On March 22, 2016, we announced the sale of our product business and all related assets to Canadian-based StrongBox Data Solutions, Inc. (“SDSI”) for gross proceeds of $1.9 million in cash. Under the purchase agreement, the Company sold and transferred all of the assets related to the Company’s product and support services division, including its StrongBox and SPHiNX products. As part of the purchase agreement, 27 of Crossroads’ employees transitioned to SDSI, and 10 employees were terminated in a reduction in force (“RIF”). Included in the transfer were assignments of ongoing contracts. In the event SDSI failed to perform such contracts, or their other assumed obligations under the purchase agreement, parties to such contracts or obligations could seek damages from the Company under certain circumstances. Depending on the claim for damages, the Company could have a claim for indemnification against SDSI pursuant to the purchase agreement. Any such indemnification claim would be subject to the provisions of the purchase agreement, as well as SDSI’s ability to pay.

Technology Licensing

We generate revenue when companies using our technology agree to pay us either an upfront licensing fee, or a combination of upfront fees and ongoing licensing fees for the use of our intellectual property. Our licensing and litigation agreements sometimes include provisions to cross-license patents from other companies, further enhancing our intellectual property assets and product capabilities. The Company’s intellectual property assets are identified in two distinct categories. The first category, known as the ’972 patent family, consists of 31 patents and pending patents that are primarily concentrated around access controls. The second category, known as the non-’972 patents, consists of 140 patents and pending patents that are primarily directed to five product families: optimizing command processing, enabling interoperability, managing networks, enhancing tape libraries, and improving data systems. On March 22, 2016, we announced that Crossroads, in partnership with Fortress Investment Group LLC (“Fortress”), signed an agreement with AQUA Licensing to market and sell the non-’972 patent portfolio. AQUA will receive a graduated commission on any revenue realized from the non-’972 patent portfolio. The Company can provide no assurance regarding the timing or value of a transaction, or even if one will occur.

Key Financial Definitions

Revenue. Revenue consists of sales of royalties we earn for licenses of certain intellectual property.

Cost of Revenue. Cost of revenue is composed of cost of royalty and other revenue. “Cost of revenue” consists of professional fees and services.

Operating Expenses. Operating expenses consist of general and administrative expenses. Personnel-related costs, which include stock-based compensation expense, are the most significant component of these expense categories. We had 6 and 48 employees as of April 30, 2016 and 2015, respectively. The majority of this reduction in headcount is related to our discontinued operations.

22 

General and Administrative Expenses. General and administrative expenses consist primarily of compensation and related costs for personnel and facilities related to our executive, finance, human resource, information technology and legal organizations, and fees for professional services. Professional services, excluding those for IP (which are included in cost of revenue), consists of outside legal, tax and audit costs.

Interest Expense. Interest expense consists of amounts charged by lenders related to interest on our line of credit and term loans, both paid and accrued.

Amortization of Debt Discount and Issuance Costs Expense. Amortization of debt discount and issuance costs expense consists of the effective interest amortization of debt, which includes the amortization of financing costs, and the fair value of the Fortress Warrants (as defined herein). It is separated from interest paid due to the material nature of both.

Other Income. Other income consists of amounts not able to be categorized elsewhere. A majority of the amounts recognized are from the partial sale of the Company’s IP revenue stream.

Discontinued Operations. Discontinued operations consist of revenue, cost of revenue, expenses, and the amounts recognized as a gain during the sale of our discontinued product and support services division.

Critical Accounting Policies and Estimates

In May 2014, the FASB amended the existing accounting standards for revenue recognition. The amendments are based on the principle that revenue should be recognized in accordance to the transfer of promised goods or services to customers, reflecting the amount of consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB issued an accounting standard update for a one-year deferral of the effective date, with an option of applying the standard on the original effective date, which for Crossroads is the first quarter of fiscal 2018. In accordance with this deferral, we are required to adopt these amendments in the first quarter of fiscal 2019. The amendments may be applied retrospectively to each prior period presented or retrospectively with the cumulative effect recognized as of the date of initial application. We are continuing to evaluate the impact of these amendments and the transition alternatives on our consolidated financial statements and disclosures.

 There have been no other material updates to our critical accounting policies and estimates set forth in “Part II—Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies and Estimates” in the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2015.

Results of Operations

Three and Six Months Ended April 30, 2016 Compared to the Three and Six Months Ended April 30, 2015

Revenue.  Revenue remained consistent for the three months ended April 30, 2016 and 2015 at $0.2 million. Revenue also remained consistent for the six months ended April 30, 2016 and 2015 at $0.4 million.

Cost of Revenue.   Cost of revenue increased $33,000, or 206.3%, to $49,000 for the three months ended April 30, 2016 from $16,000 for the three months ended April 30, 2015. Cost of revenue increased $47,000, or 88.7%, to $100,000 for the six months ended April 30, 2016 from $53,000 for the six months ended April 30, 2015. These costs of revenues are related to estimated legal costs associated with license revenue, which were higher during the 2016 periods compared to the comparative 2015 periods.

General and Administrative.  General and administrative expenses decreased $1.3 million, or 48.6%, to $1.4 million for the three months ended April 30, 2016 from $2.6 million for the three months ended April 30, 2015. The decrease was due to decreases in professional and legal services of approximately $1.0 million, decreased payroll and related expenses of $0.1 million, and decreased consulting and outside services of $0.1 million. The decreased professional fees are in connection with the decreased activity in patent and IP litigation ongoing throughout the year.

23 

General and administrative expenses decreased $0.4 million, or 9.8%, to $3.7 million for the six months ended April 30, 2016 from $4.1 million for the six months ended April 30, 2015. The decrease was due to decreases in consulting and outside services of approximately $0.1 million, decreased payroll and related expenses of $0.1 million, decreased bad debt expense of $0.1 million, and a decrease of $0.1 million in other expenses.

Interest expense.  Interest expense was $0 for the three months ended April 30, 2016 as compared to $0.1 million for the three months ended April 30, 2015. Interest expense was $0 for the six months ended April 30, 2016 as compared to $0.2 million for the six months ended April 30, 2015. The decrease was due to the payoff of the Fortress debt.

Amortization of debt discount and issuance costs.  Amortization of debt discount and issuance costs were $0 for the three months ended April 30, 2016 as compared to $0.2 million for the three months ended April 30, 2015. Amortization of debt discount and issuance costs expense were $0 for the six months ended April 30, 2016 as compared to $0.4 million for the six months ended April 30, 2015. The amortization relates to the borrowings drawn from Fortress during 2013, and the decrease is due to the Fortress debt being paid off in October 2015.

Other Income.  Other income was $0.6 million for the three months ended April 30, 2016, and $0 for the three months ended April 30, 2015. Other income was $3.3 million for the six months ended April 30, 2016, and $19,000 for the six months ended April 30, 2015. The $0.6 million recorded for the three months ended April 30, 2016, and the $3.3 million for the six months ended April 30, 2016 was the amount recognized in connection with the partial IP revenue stream sale to Techquity (as described in the Liquidity and Capital Resources section below).

Liquidity and Capital Resources

Cash Flows

Our principal liquidity requirements are to meet our working capital needs. Subject to our operating performance, which, if significantly adversely affected, would adversely affect the availability of funds, we expect to finance our operations through cash and cash equivalents provided by IP licensing, proceeds from the sale of our common stock or preferred stock, debt instruments, the sale of all or part of our non-’972 patents, and exercises of options or warrants. We may require additional capital from equity or debt financings to fund our operations or respond to strategic opportunities.

The following table summarizes our primary sources and uses of cash in the periods presented:

	Six Months Ended April 30,
	2016			2015
	(in thousands)
Net cash used in operating activities	$	(6,369	)	$	(3,740	)
Net cash provided by (used in) investing activities		824			(146	)
Net cash provided by financing activities		-			4,040
Change in cash and cash equivalents		(5,676	)		104
Cash, cash equivalents, and restricted cash, end of period		6,116			5,050

Net cash used in operating activities increased $2.6 million from approximately $3.7 million during the six months ended April 30, 2015 to approximately $6.4 million during the six months ended April 30, 2016. Net loss for the six months ended April 30, 2016 decreased approximately $5.7 million from $5.8 million for the six months ended April 30, 2015 to $0.1 million for the six months ended April 30, 2016, due primarily to the other income recognized from the partial sale of our IP revenue stream, and the sale of discontinued operations. Included in the net loss for the six months ended April 30, 2016 were non cash adjustments for stock based compensation for $0.5 million, and gain on the sale of discontinued operations of $0.9 million. Cash used in operating activities were also affected by a decrease in deferred revenue of $4.6 million as a result of the deferred revenue recognized from the partial sale of our IP revenue stream and the relief of deferred revenue due to the sale of our product operations, a decrease in accounts payable by $1.2 million due to IP legal fees paid, a decrease in accrued expenses of $0.8 million, and offset by cash provided by a decrease in accounts receivable of $0.6 million, mostly in relation to diminished activity commencing with the sale of our product business.

24 

Cash flows from investing activities primarily relate to capital expenditures to support our employees and our capital needs in our research and development efforts. Net cash used by investing activities was $0.8 million in the six months ended April 30, 2016 compared to $146,000 in cash used by investing activities during the six months ended April 30, 2015. The Company received $0.9 million in cash, net, in the sale of our discontinued operations.

Cash flows provided by financing activities for the six months ended April 30, 2015 was $4.0 million. Proceeds from the sale of common stock, and exercise of options amounted to approximately $6.0 million, offset by the repayment of debt of $2.0 million. No cash was provided by financing activities for the six months ended April 30, 2016.

Financing Arrangements

Private Placements.

On March 22, 2013, we entered into a securities purchase agreement with certain accredited investors for the issuance and sale in a private placement of 4,231,154 units at a purchase price of $2.0625 per unit, valued at $8.6 million, for net proceeds of approximately $7.9 million after related expenses.

Each unit consists of one share of 5.0% Series F convertible preferred stock (the “Series F Preferred Stock”), par value $0.001 per share and a warrant to purchase one-half of a share of common stock per share of Series F Preferred Stock purchased, at an exercise price of $2.00 per whole share, subject to certain adjustments, resulting in the issuance of warrants to purchase an additional 2,282,754 shares of common stock with an exercise price of $2.00 per share. The warrants were valued using the Black-Scholes pricing model at approximately $2,284,000 which resulted in a beneficial conversion feature on the Series F Preferred Stock of approximately $1,090,000. This amount was recorded as a deemed dividend.

The Series F Preferred Stock has the rights, qualifications, limitations and restrictions set forth in the Certificate of Designation (the “Certificate of Designation”) filed with the Secretary of State of the State of Delaware on March 28, 2013. The Certificate of Designation authorizes for issuance up to 4,500,000 shares of Series F Preferred Stock, with 3,750,000 shares designated as “Sub-Series F-1” and 750,000 shares designated as “Sub-Series F-2.” The right of holders of Series F Preferred Stock to convert the Series F Preferred Stock is subject to a 9.99% beneficial ownership limitation for holders of Sub-Series F-1 and a 4.99% beneficial ownership limitation for holders of Sub-Series F-2. Such beneficial ownership limitations may be increased or decreased by a holder of Sub-Series F-1 to any percentage not in excess of 19.99% after providing notice of such increase or decrease to the Company. For as long as at least 90% of the aggregate number of shares of Sub-Series F-1 issued on the original issue date are outstanding, the holders of such Sub-Series F-1, voting as a single class, will be entitled to elect two directors of the Company. If less than 90%, but at least 20%, of such shares of Sub-Series F-1 are outstanding, such holders, voting as a single class, will be entitled to elect one director. As of the date hereof, 78% of the aggregate number of shares of Sub-Series F-1 are outstanding, as the remainder have been voluntarily converted into common stock at the option of the holders. Therefore, the holders of Sub-Series F-1 shares are entitled to elect one director to our Board of Directors. The holders of Sub-Series F-2 will not be entitled to vote on the directors elected by the holders of Sub-Series F-1. The holders of shares of the Series F Preferred Stock are entitled to a liquidation preference equal to the original issuance price plus accrued and unpaid dividends.

The Certificate of Designation contains customary anti-dilution protection for proportional adjustments (e.g. stock splits). The Series F Preferred Stock previously included an anti-dilution provision that would adjust the conversion price of the Series F Preferred Stock to the issue price of any equity securities we issued at a price less than $2.0625 per share, subject to certain exceptions. This type of provision is commonly referred to as a “full-ratchet” anti-dilution provision. This “full-ratchet” provision is no longer in effect as it was removed from the Certificate of Designation on March 14, 2014 by the requisite approval of the holders of shares of our common stock and Series F Preferred Stock. Upon the expiration of the full ratchet anti-dilution provisions in March 2014, we reclassified the Series F Preferred Stock and warrants to permanent stockholders’ equity.

The warrants were exercisable six months after the closing date of the issuance, and expire March 22, 2018.

25 

Dividends on the Series F Preferred Stock accrue at an annual rate of 5.0% of the original issue price and are payable on a semi-annual basis. The Series F Preferred Stock ranks senior to the common stock and each other class of our capital stock, whether common, preferred or otherwise, with respect to distributions of dividends and distributions upon liquidation, dissolution or winding up of the Company. Pursuant to a registration rights agreement entered into with the purchasers of the Series F Preferred Stock, in the event that a registration statement for the resale of the common stock underlying the Series F Preferred Stock and March 2013 warrants is not declared effective prior to July 26, 2013 (120 days from the closing of the March 2013 private placement), then the rate at which dividends accrue on our Series F Preferred Stock will be increased to an annual rate of 12.0% from that date until such time as a registration statement is declared effective, at which time the dividend rate will revert to an annual rate of 5.0%. Our registration statement was not declared effective by July 26, 2013, and as a result the dividend rate on the Series F Preferred Stock increased to an annual rate of 12.0% until September 19, 2013, when that registration statement was declared effective. We may elect to satisfy our obligation to pay semi-annual dividends in cash, by distribution of common stock or a combination thereof, in our discretion.

On March 31, 2014, we entered into a securities purchase agreement with certain accredited investors for the issuance and sale in a private placement of 1,986,622 units, at a purchase price of $2.2565 per unit for net proceeds of approximately $4.5 million before expenses. Affiliates of Lone Star Value Management, LLC, of which our former Chairman of the Board of Directors serves as a managing member, purchased approximately $2.9 million of units. Roth Capital Partners acted as our financial advisor in the transaction, which was negotiated and approved by a special committee of the Board of Directors. We did not engage a placement agent in connection with the private placement, and therefore paid no commissions.

Each unit consists of one share of our common stock, par value $0.001 per share, and warrants to purchase one-half of a share of common stock, at a weighted average exercise price of $2.45 per whole share.

2015 Common Stock Offering

On January 27, 2015, we sold 3,071,739 units at $2.30 per unit for gross proceeds of $7.1 million. Each unit consists of one share of common stock and a warrant to purchase one-half of a share of common stock.  The warrants to purchase 1,658,760 shares of common stock have an exercise price of $2.76 per share.  Fees in the amount of $1.1 million relating to the stock placement were netted against proceeds.  The warrants were valued at $1.9 million using the Black-Scholes model.  The Black-Scholes inputs used were:  expected dividend rate of 0%, expected volatility of 75%, risk free interest rate of 1.55%, and expected term of 4.0 years.  The warrants are exercisable upon the six-month anniversary of issue, and expire January 31, 2020.

2015 Common Stock Rights Offering

On July 28, 2015, the Company completed a subscription rights offering for shares of the Company’s common stock (the “Rights Offering”). Under the terms of the Rights Offering, the Company distributed to its common and preferred stock holders one subscription right for each share of the Company’s common or preferred stock owned as of the record date, which entitled the holder to purchase 0.50 shares of common stock, at the subscription price of $1.25 per share, subject to certain protection mechanics in place to preserve the Company’s ability to utilize its net operating loss carryforwards (“NOLs”).

The Company accepted subscriptions for 3,933,879 shares, resulting in aggregate gross proceeds of approximately $4.9 million. Expenses incurred to complete the Rights Offering amounted to approximately $0.4 million.

IP Revenue Stream Sale

On October 30, 2015, we entered into an agreement with TQ Zeta LLC, an affiliate of Techquity, and Intrepidus Holdings LLC (collectively, “Techquity”), pursuant to which Techquity will share in the revenue generated from the ’972 patent litigation. For consideration of $10.0 million received by the Company, Techquity received the rights to 52% of the first $20 million, 40% of the amounts between $20 and $100 million, and 12% of all amounts above $100 million in aggregate licensing, settlements or other awards related to the ’972 patents received after the date of the sale agreement. We are restricted to only making payments of approved legal expenditures with the consideration received. During the six months ended April 30, 2016, the Company recognized $3.3 million in other income, and $2.9 million is held in deferred revenue and restricted cash. Included in the amount recognized as revenue during the second quarter, $0.2 million is recorded in liabilities as it is unpaid, reducing restricted cash. We recognize other income from this transaction as the authorized expenditures are made with the unspent balance being reflected as deferred revenue.

26 

Recent Accounting Pronouncements

In May 2014, the FASB amended the existing accounting standards for revenue recognition. The amendments are based on the principle that revenue should be recognized in accordance to the transfer of promised goods or services to customers, reflecting the amount of consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB issued an accounting standard update for a one-year deferral of the effective date, with an option of applying the standard on the original effective date, which for Crossroads is the first quarter of fiscal 2018. In accordance with this deferral, we are required to adopt these amendments in the first quarter of fiscal 2019. The amendments may be applied retrospectively to each prior period presented or retrospectively with the cumulative effect recognized as of the date of initial application. We are continuing to evaluate the impact of these amendments and the transition alternatives on our consolidated financial statements and disclosures.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, our management has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective (i) to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms; and (ii) to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Changes in Internal Controls

During the last fiscal quarter, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 

27 

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Patent Litigation Proceedings

We have a number of ongoing lawsuits and related proceedings as described below. In discussing these patent litigation proceedings, the following terms will be used:

· A “Markman hearing ” in a patent infringement case is a pre-trial hearing in U.S. District Court, in which the court hears arguments regarding the meanings of key words used in a disputed patent claim. The outcome of a Markman hearing can play a significant role in whether a finding of infringement and validity are made by the Court or by the jury at trial.

· An “Inter Partes Review” (“IPR”) is a post-grant review of an issued patent in which the petitioner attempts to challenge the validity of a patent on certain grounds (e.g. novelty and obviousness). If successful during inter partes review, a petitioner could potentially invalidate some or all of the claims in the patents asserted against that petitioner in related litigation, and an adverse ruling in any of these proceedings would result in invalidation or other limitations on our patent rights. An IPR, if granted, is typically a twelve-to eighteen-month process.

Crossroads v. Dot Hill

We filed a lawsuit on September 11, 2013 against Dot Hill Systems Corp. (“Dot Hill”) styled Crossroads Systems, Inc. v. Dot Hill Systems Corp., Civil Action No. 1:13-CV-800-SS alleging patent infringement of U.S. Patent No. 6,425,035 (the “’035 Patent”) and breach of the Amended Settlement and License Agreement dated June 27, 2006 between Crossroads and Dot Hill. The action is pending. The Markman hearing was conducted October 6-7, 2014. Dot Hill moved to join two existing IPR proceedings previously filed against Crossroads by other defendants (one filed by NetApp/Oracle/Huawei and one filed by Cisco/Quantum, each as defined below) and to stay the pending litigation based on those IPR proceedings. On June 16, 2015, Judge Sparks entered the Markman order (the “Markman Order”) construing the claims in a manner favorable to Crossroads and issued an order staying the case pending resolution of the IPR proceedings. The United States Patent and Trademark Office (the “U.S. Patent Office”) issued rulings in both of the IPR proceedings that Dot Hill had joined, ruling in one that the ’035 Patent is not unpatentable in view of the prior art raised and in the other that the ’035 Patent is unpatenable in view of different prior art. We believe the ruling of unpatentability was in error and has filed an appeal of that ruling with the Federal Circuit Court of Appeals. That appeal is on-going. If the patent asserted against Dot Hill is found partially or entirely invalid at the conclusion of the IPR proceedings, including appeal, we may be adversely impacted in the litigation proceeding against Dot Hill, including potentially losing the ability to continue with its claims of infringement. In May 2016, we filed a motion to lift the stay for limited purposes regarding failure of Dot Hill to pay certain royalties. A hearing took place June 2, 2016 on this motion and Crossroads anticipates the Court will decide that motion within the next two months.

Crossroads v. Oracle, Huawei, Cisco, NetApp, and Quantum

These related cases were filed on October 7, 2013, November 26, 2013, and February 18, 2014 in the United States District Court for the Western District of Texas alleging infringement by these parties of one or more patents in the ’972 patent family. The asserted patents (6,425,035, 7,934,041, 7,987,311 and 7,051,147) were subject to a re-examination of the patents conducted in 2005-2006 by the U.S. Patent Office or were issued after the re-examination. On May 7, 2014, these cases and the Dot Hill case were consolidated for purposes of discovery and a Markman hearing occurred on October 6 and 7, 2014. On June 16, 2015, Judge Sparks entered the Markman Order construing the claims in a manner favorable to Crossroads and entered an order staying these actions in light of the IPR proceedings.

During the time we were pursuing the potential infringers of the ’972 patent family, we gave companies with potentially infringing products the opportunity to license our proprietary technology. For example, NetApp was first given notice of potential infringement in 2004. Cisco was first given notice of potential infringement in 2002. Quantum has been on notice of its potential infringement since 2006. Oracle acquired several companies that were given notice of potential infringement at least as early as 2009 and Oracle itself has been on notice since then. Despite repeated attempts by Crossroads throughout the years to negotiate licenses to the ’972 patent family, these companies refused and left us with no alternatives but litigation. We believe these companies (and companies they have acquired) have been illegally using our proprietary technology and that the potential compensatory damages could be in excess of $200 million, which does not include enhanced damages or attorney fees. While the uncertainties and expense of litigation are great and we can provide no guarantees of success, we believe the infringement by most of these companies has been prolonged and potentially willful.

28 

In response to the lawsuits brought by us, collectively these defendants filed nineteen inter partes review petitions with the U.S. Patent Office to challenge the validity of the patents asserted by us in these lawsuits. The U.S. Patent Office instituted review of six of the petitions, granted joinder in four of the petitions and denied review of the remaining nine petitions. The first of the petitions were filed only months after we filed lawsuits against these parties and years after they were made aware of their potential infringement. We continue to believe it has meritorious factual and legal defenses to the challenges presented in these petitions and will vigorously defend the validity of the patents. The U.S. Patent Office issued rulings in the IPR proceedings, ruling in one that the ’035 Patent is not unpatentable in view of the prior art raised and ruling in the others that the ’035 Patent and Patent No. 7,051,147 (the “’147 Patent”) are unpatenable in view of different prior art. We believe the rulings of unpatentability were in error and has appealed these rulings to the Federal Circuit Court of Appeals. Those appeals are ongoing. If these patents, which have been asserted against Oracle, Cisco, NetApp, and Quantum are found partially or entirely invalid at the conclusion of these IPR proceedings, including appeal, we may be adversely impacted in the litigation proceedings against these companies, including potentially losing the ability to continue with its claims of infringement.

We filed a lawsuit on October 7, 2013 against Oracle Corporation (“Oracle”) alleging infringement of U.S. Patent Nos. 6,425,035, 7,051,147 and 7,934,041 (the case is styled Crossroads Systems, Inc. v. Oracle Corporation; Civil Action No. 1:13-cv-0895-SS (W.D. Tex., Austin Division)). The action is pending. The Markman hearing was conducted October 6-7, 2014 and on June 16, 2015, Judge Sparks entered the Markman Order construing the claims in a manner favorable to us. Oracle filed nine petitions for IPR at the U.S. Patent Office challenging the validity of each of the patents we asserted in the lawsuit against Oracle. The U.S. Patent Office granted six of those petitions. Based on the IPRs, Oracle filed a motion to stay the litigation pending the outcome of the IPR proceedings, which was granted by the Court. The U.S. Patent Office issued rulings in the IPR proceedings involving Oracle, ruling in one that the ’035 Patent is not unpatentable over the prior art and ruling in the other five that the ’035 Patent and ’147 Patent are unpatenable in view of different prior art. We believe the rulings of unpatentability were in error and has appealed these rulings to the Federal Circuit Court of Appeals. Those appeals are ongoing. If the patents are found partially or entirely invalid during the IPR proceedings, including appeal, we may be adversely impacted in the litigation proceeding against Oracle, including potentially losing the ability to continue with its claims of infringement.

We filed a lawsuit on February 18, 2014 against Cisco Systems, Inc. (“Cisco”) alleging infringement of U.S. Patent Nos. 6,425,035 and 7,934,041 (the case is styled Crossroads Systems, Inc. v. Cisco Systems, Inc.; Civil Action No. 1:14-cv-00148-SS (W.D. Tex., Austin Division)). The action is pending. The Markman hearing was conducted October 6-7, 2014 and on June 16, 2015, Judge Sparks entered the Markman Order construing the claims in a manner favorable to us. Cisco is a party to three petitions for IPR filed at the U.S. Patent Office challenging the validity of each of the patents we asserted in the lawsuit against Cisco. The U.S. Patent Office granted those petitions. Based on the IPRs, Cisco filed a motion to stay the litigation pending the outcome of the IPR proceedings, which was granted by the Court. The U.S. Patent Office issued rulings in the IPR proceedings involving Cisco, ruling that the ’035 Patent and ’147 Patents are unpatentable in view of the cited prior art. Crossroads believes the rulings of unpatentability were in error and has appealed these rulings to the Federal Circuit Court of Appeals. Those appeals are ongoing. If the patents are found partially or entirely invalid during the IPR proceedings, including appeal, we may be adversely impacted in the litigation proceeding against Cisco, including potentially losing the ability to continue with its claims of infringement.

We filed a lawsuit on February 18, 2014 against NetApp, Inc. (“NetApp”) alleging infringement of U.S. Patent Nos. 6,425,035, 7,934,041, 7,987,311 and 7,051,147 (the case is styled Crossroads Systems, Inc. v. Net App, Inc.; Civil Action No. 1:14-cv-00149-SS (W.D. Tex., Austin Division)). The action is pending. The Markman hearing was conducted October 6-7, 2014 and on June 16, 2015, Judge Sparks entered the Markman Order construing the claims in a manner favorable to us. NetApp filed seven petitions for IPR filed at the U.S. Patent Office challenging the validity of each of the patents we asserted in the lawsuit against NetApp. The U.S. Patent Office granted three of those petitions. Based on the IPRs, NetApp filed a motion to stay the litigation pending the outcome of the IPR proceedings, which was granted by the Court. The U.S. Patent Office issued rulings in the IPR proceedings involving NetApp, ruling in one that the ’035 Patent is not unpatentable over the prior art and ruling in the others that the ’147 Patent is unpatenable in view of different prior art. We believe the rulings of unpatentability were in error and has appealed these rulings to the Federal Circuit Court of Appeals. Those appeals are ongoing. If the patents are found partially or entirely invalid during the IPR proceedings, including appeal, we may be adversely impacted in the litigation proceeding against NetApp, including potentially losing the ability to continue with its claims of infringement.

29 

We filed a lawsuit on February 18, 2014 against Quantum Corporation (“Quantum”) alleging infringement of U.S. Patent Nos. 6,425,035 and 7,934,041 (the case is styled Crossroads Systems, Inc. v. Quantum Corporation; Civil Action No. 1:14-cv-00150-SS (W.D. Tex., Austin Division)). The action is pending. The Markman hearing was conducted October 6-7, 2014 and on June 16, 2015, Judge Sparks entered the Markman Order construing the claims in a manner favorable to us. Quantum filed three petitions for IPR filed at the U.S. Patent Office challenging the validity of each of the patents we asserted in the lawsuit against Quantum. The U.S. Patent Office granted those petitions. Based on the IPRs, Quantum filed a motion to stay the litigation pending the outcome of the IPR proceedings, which was granted by the Court. The U.S. Patent Office issued rulings in the three IPR proceedings involving Quantum, ruling that the ’035 Patent and ’147 Patents are unpatentable in view of the cited prior art. We believes the rulings of unpatenability were in error and has appealed those rulings to the Federal Circuit Court of Appeals. Those appeals are ongoing. If the patents are found partially or entirely invalid during the IPR proceedings, including appeal, we may be adversely impacted in the litigation proceeding against Quantum, including potentially losing the ability to continue with its claims of infringement.

Dot Hill v. Crossroads

On June 29, 2015, Dot Hill filed a lawsuit in the U.S. District Court for the District of Colorado alleging that our StrongBox product infringes a patent owned by Dot Hill. On April 22, 2016, the parties entered into a settlement agreement resolving the action and on May 5, 2016, the case was dismissed.

ITEM 1A. RISK FACTORS

In evaluating the Company and our common stock, we urge you to carefully consider the risks and other information in this Quarterly Report on Form 10-Q, as well as the risk factors disclosed in Item 1A to Part I of our Annual Report on Form 10-K for the fiscal year ended October 31, 2015, which we filed with the SEC on January 13, 2016. The risks and uncertainties described in “Item 1A – Risk Factors” of our Annual Report on Form 10-K have not materially changed. Any of the risks discussed in this Quarterly Report on Form 10-Q or any of the risks disclosed in Item 1A to Part I of our Annual Report on Form 10-K for the fiscal year ended October 31, 2015, as well as additional risks and uncertainties not currently known to us or that we currently deem immaterial, could materially and adversely affect our results of operations or financial condition.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

30 

ITEM 6. EXHIBITS

Exhibit No.	Description
31.1	Certification of Principal Executive Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended
31.2	Certification of Principal Financial Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended
32.1	Certification of Principal Executive Officer Required Under Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350
32.2	Certification of Principal Financial Officer Required Under Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Schema Linkbase Document
101.CAL	XBRL Taxonomy Calculation Linkbase Document
101.DEF	XBRL Taxonomy Definition Linkbase Document
101.LAB	XBRL Taxonomy Labels Linkbase Document
101.PRE	XBRL Taxonomy Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CROSSROADS SYSTEMS, INC.
June 14, 2016	/s/ Richard K. Coleman, Jr.
(Date)	Richard K. Coleman, Jr.
	President and Chief Executive Officer
	(Principal Executive Officer)
June 14, 2016	/s/ Jennifer Crane
(Date)	Jennifer Crane
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

31 

EX-31.1

Exhibit 31.1

Certification of Principal Executive Officer Required Under Rule 13a-14(a) and 15d-14(a) of
the Securities Exchange Act of 1934, as amended

I, Richard K. Coleman, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Crossroads Systems, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: June 14, 2016

/s/ Richard K. Coleman, Jr.

Richard K. Coleman, Jr.

Chief Executive Officer

EX-31.2

Exhibit 31.2

Certification of Principal Financial Officer Required Under Rule 13a-14(a) and 15d-14(a) of
the Securities Exchange Act of 1934, as amended

I, Jennifer Crane, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Crossroads Systems, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: June 14, 2016

/s/ Jennifer Crane

Jennifer Crane

Chief Financial Officer

EX-32.1

Exhibit 32.1

Certification of Principal Executive Officer Required Under Rule 13a-14(b) of
the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350

I, Richard K. Coleman, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Crossroads Systems, Inc. for the fiscal quarter ended April 30, 2016 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Crossroads Systems, Inc.

Date: June 14, 2016

/s/ Richard K. Coleman, Jr.

Richard K. Coleman, Jr.

Chief Executive Officer

EX-32.2

Exhibit 32.2

Certification of Principal Financial Officer Required Under Rule 13a-14(b) of
the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350

I, Jennifer Crane, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Crossroads Systems, Inc. for the fiscal quarter ended April 30, 2016 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Crossroads Systems, Inc.

Date: June 14, 2016

/s/ Jennifer Crane

Jennifer Crane

Chief Financial Officer

XML

Document And Entity Information - shares	6 Months Ended
	Apr. 30, 2016	Jun. 14, 2016
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Apr. 30, 2016
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q2
Entity Registrant Name	CROSSROADS SYSTEMS INC
Entity Central Index Key	0001093207
Current Fiscal Year End Date	--10-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	CRDS
Entity Common Stock, Shares Outstanding		24,509,435

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Apr. 30, 2016	Oct. 31, 2015
Current assets:
Cash and cash equivalents	$ 2,994	$ 5,314
Restricted cash	3,122	6,478
Total cash, cash equivalents and restricted cash	6,116	11,792
Accounts receivable, net of allowance for doubtful accounts of $3 and $5, respectively	1,056	656
Current assets of discontinued operations	0	1,544
Prepaid expenses and other current assets	227	218
Total current assets	7,399	14,210
Non-current assets of discontinued operations	0	562
Other assets	140	141
Total assets	7,539	14,913
Current liabilities:
Accounts payable	434	1,823
Accrued expenses	591	1,727
Deferred revenue, current portion	3,010	6,343
Current liabilities of discontinued operations	0	1,359
Total current liabilities	4,035	11,252
Non-current liabilities of discontinued operations	0	597
Commitments and contingencies (See Note 4)	0	0
Total liabilities	4,035	11,849
Stockholders' equity:
Convertible preferred stock, $0.001 par value, 25,000,000 shares authorized,2,591,257 and 2,791,257 shares issued and outstanding, respectively	3	3
Common stock, $0.001 par value, 75,000,000 shares authorized,24,509,435 and 24,182,524 shares issued and outstanding, respectively	25	24
Additional paid-in capital	239,497	238,882
Accumulated other comprehensive loss	0	(90)
Accumulated deficit	(236,021)	(235,755)
Total stockholders' equity	3,504	3,064
Total liabilities and stockholders' equity	$ 7,539	$ 14,913

XML

CONSOLIDATED BALANCE SHEETS [Parenthetical] - USD ($) $ in Thousands	Apr. 30, 2016	Oct. 31, 2015
Allowance for Doubtful Accounts (in dollars)	$ 3	$ 5
Convertible Preferred Stock, Par Value (in dollars per share)	$ 0.001	$ 0.001
Convertible Preferred Stock, Shares Authorized	25,000,000	25,000,000
Convertible Preferred Stock, Shares Issued	2,591,257	2,791,257
Convertible Preferred Stock, Shares Outstanding	2,591,257	2,791,257
Common Stock, Par Value (in dollars per share)	$ 0.001	$ 0.001
Common Stock, Shares Authorized	75,000,000	75,000,000
Common Stock, Shares Issued	24,509,435	24,182,524
Common Stock, Shares Outstanding	24,509,435	24,182,524

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 30, 2016	Apr. 30, 2015	Apr. 30, 2016	Apr. 30, 2015
Revenue:
IP license, royalty and other revenue	$ 210	$ 190	$ 420	$ 392
Cost of revenue:
IP license, royalty and other cost of revenue	49	16	100	53
Gross profit	161	174	320	339
Operating expenses:
General and administrative	1,356	2,638	3,705	4,066
Total operating expenses	1,356	2,638	3,705	4,066
Loss from operations	(1,195)	(2,464)	(3,385)	(3,727)
Other expense:
Interest expense	0	(99)	0	(227)
Amortization of debt discount and issuance costs	0	(179)	0	(400)
Other income	627	0	3,299	19
Loss from continuing operations	(568)	(2,742)	(86)	(4,335)
Discontinued operations:
Loss on discontinued operations	(1,194)	(774)	(1,812)	(1,487)
Gain on disposal of discontinued operations	1,771	0	1,771	0
Gain (loss) from discontinued operations	577	(774)	(41)	(1,487)
Net income (loss)	9	(3,516)	(127)	(5,822)
Dividends attributable to preferred stock	(78)	(72)	(129)	(156)
Net loss available to common stockholders, basic and diluted	$ (69)	$ (3,588)	$ (256)	$ (5,978)
Earnings (loss) per share, basic and diluted:
Discontinued operations (in dollars per share)	$ 0.02	$ (0.04)	$ (0.00)	$ (0.08)
Continuing operations (in dollars per share)	(0.02)	(0.14)	(0.00)	(0.25)
Available to common stockholder (in dollars per share)	$ (0.00)	$ (0.19)	$ (0.01)	$ (0.34)
Weighted average number of common shares outstanding, basic and diluted (in shares)	24,784,822	19,286,525	24,534,672	17,584,841

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 30, 2016	Apr. 30, 2015	Apr. 30, 2016	Apr. 30, 2015
Net income (loss)	$ 9	$ (3,516)	$ (127)	$ (5,822)
Other comprehensive income (loss):
Foreign currency translation adjustments	98	(11)	90	(19)
Comprehensive income (loss)	$ 107	$ (3,527)	$ (37)	$ (5,841)

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Apr. 30, 2016	Apr. 30, 2015
Cash flows from operating activities:
Net loss	$ (127)	$ (5,822)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation from discontinued operations	69	220
Gain on sale of discontinued operations	(919)	0
Amortization of debt discount	0	400
Stock-based compensation	451	536
Provision for doubtful accounts receivable	(1)	67
Changes in assets and liabilities:
Accounts receivable	630	468
Inventory	53	(167)
Prepaid expenses and other assets	48	147
Accounts payable	(1,279)	(80)
Accrued expenses	(735)	316
Accrued warranty costs	0	0
Deferred revenue	(4,559)	175
Net cash used in operating activities	(6,369)	(3,740)
Cash flows from investing activities:
Purchase of property and equipment from discontinued operations	(28)	(146)
Proceeds from sale of discontinued operations	852	0
Net cash provided by (used in) investing activities	824	(146)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of expenses	0	6,013
Repayment of debt	0	(1,973)
Net cash provided by financing activities	0	4,040
Effect of foreign exchange rate on cash and cash equivalents	(131)	(50)
Change in cash and cash equivalents	(5,676)	104
Cash, cash equivalents, and restricted cash beginning of period	11,792	4,946
Cash, cash equivalents, and restricted cash end of period	6,116	5,050
Supplemental disclosure of cash flow information:
Cash paid for interest	0	227
Cash paid for income taxes	2	1
Supplemental disclosure of non cash financing activities:
Conversion of preferred stock to common stock	302	418
Common stock dividends issued to preferred shareholders	139	169
Warrants issued with private placement stock	0	1,893
Lease incentive received, non-cash addition to fixed assets	$ 0	$ 243

XML

ORGANIZATION AND BASIS OF PRESENTATION

6 Months Ended

Apr. 30, 2016

Organization, Consolidation and Presentation Of Financial Statements [Abstract]

Basis of Accounting [Text Block]

1. ORGANIZATION AND BASIS OF PRESENTATION

The accompanying consolidated financial statements include the accounts of Crossroads Systems, Inc. and its wholly-owned subsidiaries (“Crossroads” or the “Company”).   Headquartered in Austin, Texas, Crossroads, a Delaware corporation, is an intellectual property licensing company. Founded in 1996 as a product solutions company, Crossroads created some of the storage industry's most fundamental patents and has licensed patents to more than 50 companies since 2000.

Principles of Consolidation and presentation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation.

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has accumulated significant losses as it has been developing its current and next generation products. The Company believes that cash flow from operations, customer reimbursed expenses, and proceeds from the sale of common and preferred stock will be sufficient to fund the anticipated operations for the next 12 months.  These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern for a reasonable period of time.

The investment in KIP CR P1 LP (which we refer to as the “partnership”), of which the Company is a limited partner and of which an affiliate of Fortress Investment Group LLC (“Fortress”) is the general partner, is accounted for using the equity method. The partnership holds the Company’s non’972 patent portfolio. The current investment balance is nominal at April 30, 2016.

Use of Estimates

The preparation of the consolidated financial statements in conformity with generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates, and such differences may be material to the consolidated financial statements.

Reclassification

Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassification includes assets, liabilities, and certain expenses in sales and marketing, research and development, and general and administrative related to discontinued operations. The amounts for the prior periods have been reclassified to be consistent with the current period presentation and have no impact on previously reported financials.

Cash, Cash Equivalents, and Restricted Cash

Cash, cash equivalents, and restricted cash consist of cash on deposit and highly liquid investments with original maturities of 90 days or less at date of purchase. While the Company’s cash and cash equivalents are on deposit with high quality FDIC and Association of German Banks insured financial institutions, at times such deposits exceed insured limits. As of April 30, 2016, total uninsured deposits were $5.8 million. The Company has not experienced any losses in such accounts.

Restricted cash amounted to $3.1 million. The balance consists of $2.9 million in cash held from the sale of a portion of the Company’s IP revenue stream, and $0.2 million in connection with a letter of credit on the lease of the Company headquarters.

IP Revenue Stream Sale

On October 30, 2015, the Company entered into an agreement with TQ Zeta LLC, an affiliate of Techquity, and Intrepidus Holdings LLC (collectively, “Techquity”), in which Techquity will share in the revenue generated from the ‘972 patent litigation. For consideration of $10.0 million received by the Company, Techquity received the rights to 52% of the first $20 million in licenses, settlements or other awards related to the ‘972 patents, 40% of the amounts between $20 and $100 million, and 12% of all amounts above $100 million in aggregate licensing, settlements or other awards. Proceeds from the TQ Zeta agreement are restricted to approved legal expenditures as defined in the agreement. During the three and six months ended April 30, 2016, the Company recognized $0.6 and $3.3 million in other income, respectively, $2.9 million is held in deferred revenue and restricted cash. Included in the amount recognized as revenue during the three and six months ended April 30, 2016 is $0.2 million recorded in liabilities, reducing restricted cash. The Company will recognize other income from this transaction as the authorized expenditures are made with the unspent balance being reflected as deferred revenue.

Contracts to Modify or Customize Products

The Company has entered into contracts with certain customers to significantly modify or customize products. In accounting for such arrangements, we first look to the guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 985-605, Software - Revenue Recognition (“ASC 985-605”), and then ASC Subtopic 605-25, Revenue Recognition – Multiple-Element Arrangements, to determine the appropriate accounting elements in the arrangement.  The Company then considers the appropriate recognition model for each accounting element based on the nature of the element and apply the guidance in ASC Subtopic 605-35, Revenue Recognition – Construction-Type and Production-Type Contracts, ASC Subtopic 985-60, ASC Subtopic 605-15, Revenue Recognition – Products, or ASC Subtopic 605-20, Revenue Recognition – Services, as applicable.  Amounts allocated to the modification/customization service element are evaluated for classification in the consolidated statement of operations as either revenue or reduction of research and development expense based on the following considerations: whether and in what circumstances the consideration received is refundable, ownership of the final product and intellectual property rights to develop the product, and exclusivity of the final product.

Computation of Net Loss Per Share

Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share is computed by giving effect to all dilutive potential common shares that were outstanding during the period. Basic earnings per share excludes the dilutive effect of common stock equivalents such as stock options and warrants, while earnings per share, assuming dilution, includes such dilutive effects. Future weighted-average shares outstanding calculations will be impacted by the following factors, among others: (i) the ongoing issuance of common stock associated with stock option and warrant exercises; (ii) any fluctuations in the Company’s stock price, which could cause changes in the number of common stock equivalents included in the earnings per share, assuming dilution computation; and (iii) the issuance of common stock to effect business combinations should the Company enter into such transactions.

The Company has excluded all outstanding common stock equivalents from the calculation of diluted net loss per share because all such common stock equivalents are antidilutive for all periods presented. The total number of common stock equivalents excluded from the diluted net loss per common share calculation was 13,776,052 and 13,411,599 for the six months ended April 30, 2016 and 2015, respectively. The dilutive common stock equivalents for the six months ended April 30, 2016 include warrants to purchase 7,375,327 shares of common stock, 2,591,257 shares of preferred stock, which are excluded until converted to common shares (Note 6), and stock options to purchase 3,809,468 shares of common stock.

Net loss available to common stockholders is calculated by deducting from net income, preferred dividends paid and accrued of $78,000 and $129,000 for the three and six months ended April 30, 2016, respectively.

Recently Issued Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) amended the existing accounting standards for revenue recognition. The amendments are based on the principle that revenue should be recognized in accordance to the transfer of promised goods or services to customers, reflecting the amount of consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB issued an accounting standard update for a one-year deferral of the effective date, with an option of applying the standard on the original effective date, which for Crossroads is the first quarter of fiscal 2018. In accordance with this deferral, the Company is required to adopt these amendments in the first quarter of fiscal 2019. The amendments may be applied retrospectively to each prior period presented or retrospectively with the cumulative effect recognized as of the date of initial application. The Company is continuing to evaluate the impact of these amendments and the transition alternatives on its consolidated financial statements and disclosures. 

The Company has implemented all new accounting pronouncements that are in effect and that may impact its consolidated financial statements. The Company does not believe that there are any new accounting pronouncements that have been issued that might have a material impact on its consolidated financial position or results of operations.

XML

FAIR VALUE MEASUREMENT

6 Months Ended

Apr. 30, 2016

Fair Value Disclosures [Abstract]

Fair Value Disclosures [Text Block]

2. FAIR VALUE MEASUREMENT

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measurements, a three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies, is applied as follows:

Level 1 – Valuations based on quoted prices for identical assets and liabilities in active markets.

Level 2 –  Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data.

Level 3 – Valuations based on unobservable inputs reflecting management’s assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.

As of April 30, 2016, the fair value of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximates book value due to the short maturity of these instruments. Based upon borrowing rates currently available to the Company for loans with similar terms, the carrying value of its debt obligations approximates fair value. As of April 30, 2016 and October 31, 2015, the Company held no investments.

XML

ACCRUED EXPENSES AND DEFERRED REVENUE

6 Months Ended

Apr. 30, 2016

Payables and Accruals [Abstract]

Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]

3. ACCRUED EXPENSES AND DEFERRED REVENUE

Accrued expenses consist of the following (in thousands):

	April 30,		October 31,
	2016		2015
	(unaudited)
Payroll related	$	162	$	837
Professional services		340		657
Deferred rent		-		184
Warranty reserve		-		5
Other		89		44
	$	591	$	1,727

Included in payroll related accrued expenses as of April 30, 2016 and October 31, 2015 was $0.1 and $0.4 million, respectively, related to bonus compensation.

Deferred revenue, current portion, consists of the following (in thousands):

	April 30,		October 31,
	2016		2015
	(unaudited)
License	$	104	$	135
Deferred revenue stream sale		2,906		6,208
	$	3,010	$	6,343

Deferred revenue stream sale consists of the remaining amount of consideration received from the sale of a portion of the Company’s IP revenue stream. The deferred revenue will be recognized upon the expenditure of approved legal costs related to the ongoing IP litigation described in Note 4.

XML

COMMITMENTS AND CONTINGENCIES

6 Months Ended

Apr. 30, 2016

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

4. COMMITMENTS AND CONTINGENCIES

Leases

In accordance with the terms of the March 22, 2016 sale of our product division, the Company’s office space and equipment lease obligations have been assigned to the purchaser.

Intellectual Property Litigation

The Company has a number of ongoing lawsuits and related proceedings as described below. In discussing these patent litigation proceedings, the following terms will be used:

A “Markman hearing” in a patent infringement case is a pre-trial hearing in U.S. District Court, in which the Court hears arguments regarding the meanings of key words used in a disputed patent claim. The outcome of a Markman hearing can play a significant role in whether findings of infringement and validity are made by the Court or by the jury at trial. Depending on the Court, a ruling could be received quickly or could take months after the Markman hearing.

An “Inter Partes Review,” or “IPR,” is a post-grant review of an issued patent in which the petitioner attempts to challenge the validity of a patent on certain grounds (e.g. novelty and obviousness). If successful during inter partes review, a petitioner could potentially invalidate some or all of the claims in the patents asserted against that petitioner in related litigation, and an adverse ruling in any of these proceedings would result in invalidation or other limitations on the Company’s patent rights. Inter partes review, if granted, is typically a twelve- to eighteen-month process from institution.

Crossroads v. Dot Hill

The Company filed a lawsuit on September 11, 2013 against Dot Hill Systems Corp. ("Dot Hill") styled Crossroads Systems, Inc. v. Dot Hill Systems Corp., Civil Action No. 1:13-CV-800-SS alleging patent infringement of U.S. Patent No. 6,425,035 (the “035 patent”) and breach of the Amended Settlement and License Agreement dated June 27, 2006 between Crossroads and Dot Hill. The action is pending. The Markman hearing was conducted October 6-7, 2014. Dot Hill moved to join two existing IPR proceedings previously filed against Crossroads by other defendants (one filed by NetApp/Oracle/Huawei and one filed by Cisco/Quantum, each as defined below) and to stay the pending litigation based on those IPR proceedings. On June 16, 2015, Judge Sparks entered the Markman order (the “Markman Order”) construing the claims in a manner favorable to Crossroads and issued an order staying the case pending resolution of the IPR proceedings. The United States Patent and Trademark Office (the “U.S. Patent Office”) issued rulings in both of the IPR proceedings that Dot Hill had joined, ruling in one that the ‘035 Patent is not unpatentable in view of the prior art raised and in the other that the ‘035 Patent is unpatenable in view of different prior art. Crossroads believes the ruling of unpatentability was in error and has filed an appeal of that ruling with the Federal Circuit Court of Appeals. That appeal is on-going. If the patent asserted against Dot Hill is found partially or entirely invalid at the conclusion of the IPR proceedings, including appeal, Crossroads might be adversely impacted in the litigation proceeding against Dot Hill, including potentially losing the ability to continue with its claims of infringement. In May 2016, Crossroads filed a motion to lift the stay for limited purposes regarding Dot Hill’s failure to pay certain royalties. A hearing took place June 2, 2016 on this motion and Crossroads anticipates the Court will decide that motion within the next two months.

Dot Hill owes the Company approximately $1.0 million at April 30, 2016 related to an agreement between the companies. The Company believes these amounts have been earned and collectability is probable at April 30, 2016.

Crossroads v. Oracle, Huawei, Cisco, NetApp, and Quantum

These related cases were filed on October 7, 2013, November 26, 2013, and February 18, 2014 in the United States District Court for the Western District of Texas alleging infringement by these parties of one or more patents in the ‘972 patent family. The asserted patents (6,425,035, 7,934,041, 7,987,311 and 7,051,147) were subject to a re-examination of the patents conducted in 2005-2006 by the U.S. Patent Office or were issued after the re-examination. On May 7, 2014, these cases and the Dot Hill case were consolidated for purposes of discovery and a Markman hearing occurred on October 6 and 7, 2014. On June 16, 2015, Judge Sparks entered the Markman Order construing the claims in a manner favorable to Crossroads and entered an order staying these actions in light of the IPR proceedings.

During the time Crossroads was pursuing the potential infringers of the ‘972 patent family, the Company gave companies with potentially infringing products the opportunity to license the Company’s proprietary technology. For example, NetApp was first given notice of potential infringement in 2004. Cisco was first given notice of potential infringement in 2002. Quantum has been on notice of its potential infringement since 2006. Oracle acquired several companies that were given notice of potential infringement at least as early as 2009 and Oracle itself has been on notice since then. Despite repeated attempts by Crossroads throughout the years to negotiate licenses to the ‘972 patent family, these companies refused and left Crossroads with no alternatives but litigation. Crossroads believes these companies (and companies they have acquired) have been illegally using Crossroads’ proprietary technology and that the potential compensatory damages could be in excess of $200 million, which does not include enhanced damages or attorney fees. While the uncertainties and expense of litigation are great and the Company can provide no guarantees of success, the Company believes the infringement by most of these companies has been prolonged and potentially willful.

In response to the lawsuits brought by Crossroads, collectively these defendants filed nineteen inter partes review petitions with the U.S. Patent Office to challenge the validity of the patents asserted by the Company in these lawsuits. The U.S. Patent Office instituted review of six of the petitions, granted joinder in four of the petitions and denied review of the remaining nine petitions. The first of the petitions were filed only months after Crossroads filed lawsuits against these parties and years after they were made aware of their potential infringement. Crossroads continues to believe it has meritorious factual and legal defenses to the challenges presented in these petitions and will vigorously defend the validity of the patents. The U.S. Patent Office issued rulings in the IPR proceedings, ruling in one that the ‘035 Patent is not unpatentable in view of the prior art raised and ruling in the others that the ‘035 Patent and Patent No. 7,051,147 (the “’147 Patent”) are unpatenable in view of different prior art. Crossroads believes the rulings of unpatentability were in error and has appealed these rulings to the Federal Circuit Court of Appeals. Those appeals are on-going. If these patents, which have been asserted against Oracle, Cisco, NetApp, and Quantum, are found partially or entirely invalid at the conclusion of these IPR proceedings, including appeal, Crossroads might be adversely impacted in the litigation proceedings against these companies, including potentially losing the ability to continue with its claims of infringement.

The Company filed a lawsuit on October 7, 2013 against Oracle Corporation (“Oracle”) alleging infringement of U.S. Patent Nos. 6,425,035, 7,051,147 and 7,934,041 (the case is styled Crossroads Systems, Inc. v. Oracle Corporation; Civil Action No. 1:13-cv-0895-SS (W.D. Tex., Austin Division)). The action is pending. The Markman hearing was conducted October 6-7, 2014 and on June 16, 2015, Judge Sparks entered the Markman Order construing the claims in a manner favorable to Crossroads. Oracle filed nine petitions for IPR at the U.S. Patent Office challenging the validity of each of the patents Crossroads asserted in the lawsuit against Oracle. The U.S. Patent Office granted six of those petitions. Based on the IPRs, Oracle filed a motion to stay the litigation pending the outcome of the IPR proceedings, which was granted by the Court. The U.S. Patent Office issued rulings in the IPR proceedings involving Oracle, ruling in one that the ‘035 Patent is not unpatentable over the prior art and ruling in the other five that the ‘035 Patent and ‘147 Patent are unpatenable in view of different prior art. Crossroads believes the rulings of unpatentability were in error and has appealed these rulings to the Federal Circuit Court of Appeals. Those appeals are on-going. If the patents are found partially or entirely invalid during the IPR proceedings, including appeal, Crossroads might be adversely impacted in the litigation proceeding against Oracle, including potentially losing the ability to continue with its claims of infringement.

The Company filed a lawsuit on February 18, 2014 against Cisco Systems, Inc. (“Cisco”) alleging infringement of U.S. Patent Nos. 6,425,035 and 7,934,041 (the case is styled Crossroads Systems, Inc. v. Cisco Systems, Inc.; Civil Action No. 1:14-cv-00148-SS (W.D. Tex., Austin Division)). The action is pending. The Markman hearing was conducted October 6-7, 2014 and on June 16, 2015, Judge Sparks entered the Markman Order construing the claims in a manner favorable to Crossroads. Cisco is a party to three petitions for IPR filed at the U.S. Patent Office challenging the validity of each of the patents Crossroads asserted in the lawsuit against Cisco. The U.S. Patent Office granted those petitions. Based on the IPRs, Cisco filed a motion to stay the litigation pending the outcome of the IPR proceedings, which was granted by the Court. The U.S. Patent Office issued rulings in the IPR proceedings involving Cisco, ruling that the ‘035 Patent and ‘147 Patents are unpatentable in view of the cited prior art. Crossroads believes the rulings of unpatentability were in error and has appealed these rulings to the Federal Circuit Court of Appeals. Those appeals are on-going. If the patents are found partially or entirely invalid during the IPR proceedings, including appeal, Crossroads might be adversely impacted in the litigation proceeding against Cisco, including potentially losing the ability to continue with its claims of infringement.

The Company filed a lawsuit on February 18, 2014 against NetApp, Inc. (“NetApp”) alleging infringement of U.S. Patent Nos. 6,425,035, 7,934,041, 7,987,311 and 7,051,147 (the case is styled Crossroads Systems, Inc. v. Net App, Inc.; Civil Action No. 1:14-cv-00149-SS (W.D. Tex., Austin Division)). The action is pending. The Markman hearing was conducted October 6-7, 2014 and on June 16, 2015, Judge Sparks entered the Markman Order construing the claims in a manner favorable to Crossroads. NetApp filed seven petitions for IPR filed at the U.S. Patent Office challenging the validity of each of the patents Crossroads asserted in the lawsuit against NetApp. The U.S. Patent Office granted three of those petitions. Based on the IPRs, NetApp filed a motion to stay the litigation pending the outcome of the IPR proceedings, which was granted by the Court. The U.S. Patent Office issued rulings in the IPR proceedings involving NetApp, ruling in one that the ‘035 Patent is not unpatentable over the prior art and ruling in the others that the ‘147 Patent is unpatenable in view of different prior art. Crossroads believes the rulings of unpatentability were in error and has appealed these rulings to the Federal Circuit Court of Appeals. Those appeals are on-going. If the patents are found partially or entirely invalid during the IPR proceedings, including appeal, Crossroads might be adversely impacted in the litigation proceeding against NetApp, including potentially losing the ability to continue with its claims of infringement.

The Company filed a lawsuit on February 18, 2014 against Quantum Corporation (“Quantum”) alleging infringement of U.S. Patent Nos. 6,425,035 and 7,934,041 (the case is styled Crossroads Systems, Inc. v. Quantum Corporation; Civil Action No. 1:14-cv-00150-SS (W.D. Tex., Austin Division)). The action is pending. The Markman hearing was conducted October 6-7, 2014 and on June 16, 2015, Judge Sparks entered the Markman Order construing the claims in a manner favorable to Crossroads. Quantum filed three petitions for IPR filed at the U.S. Patent Office challenging the validity of each of the patents Crossroads asserted in the lawsuit against Quantum. The U.S. Patent Office granted those petitions. Based on the IPRs, Quantum filed a motion to stay the litigation pending the outcome of the IPR proceedings, which was granted by the Court. The U.S. Patent Office issued rulings in the three IPR proceedings involving Quantum, ruling that the ‘035 Patent and ‘147 Patents are unpatentable in view of the cited prior art. Crossroads believes the rulings of unpatenability were in error and has appealed those rulings to the Federal Circuit Court of Appeals. Those appeals are on-going. If the patents are found partially or entirely invalid during the IPR proceedings, including appeal, Crossroads might be adversely impacted in the litigation proceeding against Quantum, including potentially losing the ability to continue with its claims of infringement.

Dot Hill v. Crossroads

On June 29, 2015, Dot Hill filed a lawsuit in the U.S. District Court for the District of Colorado alleging that the Company’s StrongBox product infringed a patent owned by Dot Hill. On April 22, 2016 the parties entered into a settlement agreement resolving the action and on May 5, 2016, the case was dismissed.

XML

DISCONTINUED OPERATIONS

6 Months Ended

Apr. 30, 2016

Discontinued Operations and Disposal Groups [Abstract]

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

5. DISCONTINUED OPERATIONS

On March 22, 2016, the Company entered into a Purchase and Assignment Agreement (the “Purchase Agreement”) with StrongBox Data Solutions, Inc. (“SDSI”), a Quebec corporation.

Under the Purchase Agreement, the Company sold and transferred all of the assets related to the Company’s product and support services division (the “Business”), including the Company’s StrongBox and SPHiNX storage solutions, to SDSI. SDSI also assumed certain liabilities of the Company related to the Company’s product business, and absorbed the majority of Crossroads’ employees. As consideration under the Purchase Agreement, SDSI paid the Company net proceeds equal to $1.9 million in cash on the closing date. Consideration of $1.0 million was paid to the holders of the Company’s Series F Preferred Stock in exchange for a vote for approval of the divestiture. The Board of Directors approved this payment, which has been reflected as a cost to sell the business.

The assets and liabilities transferred for consideration received were (in thousands, at book value, unaudited):

Cash Received	$	1,852
Cash paid to Series F Convertible Preferred shareholders		(1,000)
Net cash received		852
Fixed Assets		(499)
Inventory		(386)
Other Comprehensive Income		(110)
Expenses incurred		(79)
Deferred Revenue		1,795
Other Assets and Liabilities		198
Net gain on sale of discontinued operations	$	1,771

Certain items were reclassified as part of discontinued operations for comparative purposes. The table below presents the amounts by balance sheet classification (in thousands):

	April 30,		October 31,
	2016		2015
Assets	(unaudited)		(unaudited)
Current assets:
Accounts receivable, net	$	-	$	976
Inventories		-		437
Prepaids expenses, and other current assets		-		131
Total current assets		-		1,544
Property and equipment, net		-		533
Other assets		-		30
Total assets	$	-	$	2,107
Liabilities
Current liabilities:
Accounts payable		-		400
Accrued expenses		-		68
Deferred revenue		-		891
Total current liabilities		-		1,359
Long term deferred revenue		-		596
Total liabilities	$	-	$	1,955

The amounts in the statement of operations that are part of the discontinued operations are summarized in the following table (in thousands):

	Three Months Ended				Six Months Ended
	April 30,				April 30,
	2016		2015		2016		2015
Revenue:	(unaudited)		(unaudited)		(unaudited)		(unaudited)
Product	$	-	$	584	$	859	$	1,446
IP License, royalty and other		(63)		946		923		2,053
Total revenue		(63)		1,530		1,782		3,499
Cost of revenue:
Product		-		220		309		502
IP License, royalty and other		41		176		275		433
Total cost of revenue		41		396		584		935
Gross profit		(104)		1,134		1,198		2,564
Operating expenses:
Sales and marketing		452		829		1,275		1,700
Research and development		638		1,079		1,735		2,351
Total operating expenses		1,090		1,908		3,010		4,051
(Loss) income from discontinued operations	$	(1,194)	$	(774)	$	(1,812)	$	(1,487)

XML

STOCKHOLDERS' EQUITY

6 Months Ended

Apr. 30, 2016

Stockholders Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

6. STOCKHOLDERS’ EQUITY

2013 Private Placement

On March 22, 2013, the Company entered into a securities purchase agreement with certain accredited investors for the issuance and sale in a private placement of 4,231,154 units at a purchase price of $2.0625 per unit, valued at $8.6 million, for net proceeds of approximately $7.9 million after related expenses. Each unit consists of one share of cumulative 5.0% Series F convertible preferred stock (“Series F Preferred Stock”), par value $0.001 per share, and a warrant to purchase one-half of a share of common stock per share of Series F Preferred Stock purchased, at an exercise price of $2.00 per whole share, subject to certain adjustments, resulting in the issuance of warrants to purchase an additional 2,282,754 shares of common stock with an exercise price of $2.00 per share. In connection with the 2015 Common Stock Rights Offering, defined below, an additional 0.2019 warrants were granted for every outstanding warrant on August 31, 2015. As of April 30, 2016, there were 2,439,585 warrants outstanding. The Series F Preferred Stock ranks senior to the common stock and each other class or series of the Company’s capital stock, whether common, preferred or otherwise, with respect to distributions of dividends and distributions upon liquidation, dissolution or winding up of the Company. The warrants were initially valued using the Black-Scholes pricing model at approximately $2,284,000.  The relative fair value of these warrants totaling $1,543,000 was initially allocated to additional paid in capital.  The Black-Scholes inputs used were:  expected dividend rate of 0 %, expected volatility of 63%, risk free interest rate of 0.82%, and expected term of 5 years.  This valuation resulted in a beneficial conversion feature on the Series F Preferred Stock of approximately $1,090,000, which was recorded as a deemed dividend.  Fees in the amount of $0.7 million relating to the stock placement were netted against proceeds. The warrants were exercisable immediately upon issue, and expire March 22, 2018.  During the six months ended April 30, 2015, the Company issued 67,781 dividend common shares valued at approximately $169,000. During the six months ended April 30, 2016, the Company issued a dividend of 126,911 common shares valued at approximately $302,000. Accrued and unpaid dividends were valued at approximately $88,000 as of April 30, 2016.

The Series F Preferred Stock has the rights, qualifications, limitations and restrictions set forth in the Certificate of Designation (the “Certificate of Designation”) filed with the Secretary of State of the State of Delaware on March 28, 2013. The Certificate of Designation authorizes issuance of up to 4,500,000 shares of Series F Preferred Stock, with 3,750,000 shares designated as “Sub-Series F-1” and 750,000 shares designated as “Sub-Series F-2.” The right of holders of Series F Preferred Stock to convert the Series F Preferred Stock is subject to a 9.99% beneficial ownership limitation for holders of Sub-Series F-1 and a 4.99% beneficial ownership limitation for holders of Sub-Series F-2. Such beneficial ownership limitations may be increased or decreased by a holder of Sub-Series F-1 to any percentage not in excess of 19.99% after providing notice of such increase or decrease to the Company. For as long as at least 90% of the aggregate number of shares of Sub-Series F-1 issued on the original issue date are outstanding, the holders of such Sub-Series F-1, voting as a single class, will be entitled to elect two directors of the Company. If less than 90%, but at least 20%, of such shares of Sub-Series F-1 are outstanding, such holders, voting as a single class, will be entitled to elect one director of the Company. As of the date hereof, less than 78% of the aggregate number of shares of Sub-Series F-1 are outstanding, as the remainder have been voluntarily converted into common stock at the option of the holders. Therefore, the holders of the Sub-Series F-1 shares are entitled to elect one director to the Board of Directors. The holders of Sub-Series F-2 will not be entitled to vote on the directors elected by the holders of Sub-Series F-1. The holders of shares of the Series F Preferred Stock are entitled to a liquidation preference equal to the original issuance price plus any unpaid dividends.

The Certificate of Designation contains customary anti-dilution protection for proportional adjustments (e.g. stock splits). The Series F Preferred Stock previously included an anti-dilution provision that would adjust the conversion price of the Series F Preferred Stock to the issue price of any equity securities the Company issued at a price less than $2.0625 per share, subject to certain exceptions. This type of provision is commonly referred to as a “full-ratchet” anti-dilution provision.    

Upon approval of the full ratchet anti-dilution provisions on June 21, 2013, the warrants were reclassified as a derivative liability and recorded at fair value. This created a scenario for which the shares of Series F Preferred Stock were potentially convertible into more shares of common stock than authorized. Therefore, the Series F Preferred Stock was classified in temporary equity. Upon the expiration of the full ratchet anti-dilution provisions in March 2014, the Company reclassified the Series F Preferred Stock and warrants to permanent stockholders' equity following the stockholders vote.

During the six months ended April 30, 2016, 200,000 shares of Series F Preferred Stock were converted to common shares.

Dividends on the Series F Preferred Stock accrue at an annual rate of 5.0% of the original issue price and are payable on a semi-annual basis. The Series F Preferred Stock ranks senior to the common stock and each other class or series of the Company’s capital stock, whether common, preferred or otherwise, with respect to distributions of dividends and distributions upon liquidation, dissolution or winding up of the Company. The Company may elect to satisfy the obligation to pay semi-annual dividends in cash, by distribution of common stock or a combination thereof, in the Company’s discretion.

2013 Fortress Credit Agreement

On July 22, 2013 the Company issued warrants to purchase 1,454,545 shares of its common stock to Fortress at $2.0625 per share (the “Fortress Warrants”). To derive an estimate of the fair value of these warrants, the Company utilized a dynamic Black-Scholes formula that computes the impact of share dilution upon the exercise of the warrant shares. This process relies upon inputs such as shares outstanding, estimated stock prices, strike price and volatility assumptions to dynamically adjust the payoff of the warrants in the presence of the dilution effect.   The Fortress Warrants were recorded at a fair value of $1,374,000 or $1.0625 per underlying warrant share. In connection with the Offering (as defined below), an additional 0.2019 warrants were granted for every outstanding warrant on August 31, 2015, with the strike price remaining at $2.0625. As of April 30, 2016, there were 1,748,218 warrants outstanding.

The Fortress Warrants will expire on the seventh anniversary of the effective date of the Fortress transactions.

2014 Private Placement

On March 31, 2014, the Company sold 1,986,622 units at $2.2565 per unit for gross proceeds to the Company of $4.5 million. Each unit consists of one share of common stock and a warrant to purchase one-half of a share of common stock.  The warrants to purchase 993,311 shares of common stock have a weighted average exercise price of $2.45 per share.  Fees in the amount of $0.2 million relating to the stock placement were netted against proceeds.  The warrants were valued at $1.1 million using the Black-Scholes model.  The Black-Scholes inputs used were:  expected dividend rate of 0%, expected volatility of 74%, risk free interest rate of 1.64%, and expected term of 2.5 years.  The warrants were exercisable upon the six-month anniversary of issue, and expire March 31, 2019. In connection with the Offering, an additional 0.2019 warrants were granted for every outstanding warrant on August 31, 2015, with the strike price remaining at $2.45. As of April 30, 2016, there were 1,193,860 warrants outstanding. 

2015 Common Stock Offering

On January 27, 2015, the Company sold 3,071,739 units at $2.30 per unit for gross proceeds to the Company of $7.1 million. Each unit consists of one share of common stock and a warrant to purchase one-half of a share of common stock.  The warrants to purchase 1,658,760 shares of common stock have an exercise price of $2.76 per share.   Fees in the amount of $1.1 million relating to the stock placement were netted against proceeds.  The warrants were valued at $1.9 million using the Black-Scholes model.  The Black-Scholes inputs used were:  expected dividend rate of 0%, expected volatility of 75%, risk free interest rate of 1.55%, and expected term of 4.0 years.  The warrants will be exercisable upon the six-month anniversary of issue, and expire January 31, 2020. In connection with the Offering an additional 0.2019 warrants were granted for every outstanding warrant on August 31, 2015, with the strike price remaining at $2.76. As of April 30, 2016, there were 1,993,664 warrants outstanding. 

2015 Common Stock Rights Offering

On July 28, 2015, the Company completed a subscription rights offering for shares of the Company’s common stock (the “Rights Offering”). Under the terms of the Rights Offering, the Company distributed to its common and preferred stock holders one subscription right for each share of the Company’s common or preferred stock owned as of the record date, which entitled the holder to purchase 0.50 shares of common stock, at the subscription price of $1.25 per share, subject to certain protection mechanics in place to preserve the Company's ability to utilize its net operating loss carryforwards ("NOLs").

The Company accepted subscriptions for 3,933,879 shares, resulting in aggregate gross proceeds of approximately $4.9 million. Expenses incurred to complete the Rights Offering amounted to approximately $0.4 million.

The Company has the following common stock warrants outstanding at April 30, 2016:

Warrant Transaction	Warrants Outstanding		Weighted Average Exercise Price
2013 Private Placement		2,439,585	$	2.00
2013 Fortress Credit Agreement		1,748,218	$	2.06
2014 Private Placement		1,193,860	$	2.45
2015 Common Stock Offering		1,993,664	$	2.76
Total Warrants		7,375,327

XML

STOCK OPTIONS AND STOCK BASED COMPENSATION

6 Months Ended

Apr. 30, 2016

Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

7. STOCK OPTIONS AND STOCK BASED COMPENSATION

The Company has a stock-based compensation plan available to grant incentive stock options, non-qualified stock options and restricted stock to employees and non-employee members of the Board of Directors and advisors.

The Company’s 2010 Stock Incentive Plan (the “2010 Plan”) succeeded the 1999 Stock Option/Stock Issuance Plan (the “1999 Plan”).  As of April 30, 2016, options to purchase 285,683 shares of common stock were outstanding under the 1999 Plan, and no further grants can be made under the 1999 Plan.

The 2010 Plan was approved by the Board of Directors on May 26, 2010 and became effective on August 13, 2010, upon approval by stockholders, and was subsequently amended by the Board of Directors on March 12, 2015 and approved by stockholders on April 24, 2015.  A maximum of 5,250,000 shares of Crossroads common stock may be awarded.  As of April 30, 2016, options to purchase 5,304,943 shares of common stock were granted from the 2010 Plan, of which 3,523,785 were outstanding. During the six months ended April 30, 2016 and 2015, 0 and 117,577 common stock shares were granted from the 2010 Plan, respectively.

As of April 30, 2016, options to purchase an aggregate of 3,809,468 shares of common stock were outstanding under the 1999 Plan and the 2010 Plan, of which 3,220,395 were vested. Under the 2010 Plan, 785,302 shares of common stock were available for future grants as of April 30, 2016.  The shares of common stock reserved for future grant are reduced by 526,741 options previously exercised under the 2010 Plan, and 414,172 shares of stock granted under the 2010 Plan.  The Compensation Committee of the Board of Directors determines the exercise price, term and other conditions applicable to each stock option granted under the 2010 Plan. The exercise price of stock options is set on the grant date and may not be less than the fair market value per share of the Company’s stock on that date (at market close). The 2010 Plan options generally become exercisable over a four-year period (vesting 25% after one year, the remaining 75% vesting quarterly thereafter) and expire after ten years. The majority of the employee incentive stock option grants vest on a schedule of 25% at the end of six months and 12.5% thereafter until fully vested. Stock option exercises are fulfilled with new shares of common stock.

The Company realized stock-based compensation expense for all awards issued under the Company’s stock plans in the following line items in the consolidated statements of operations:

	Six months ended April 30,
	2016		2015
General and administrative	$	348	$	332
Discontinued operations		103		204
Total stock-based compensation	$	451	$	536

The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model. Expected volatility is based on historical volatility of the Company’s common stock. The expected term represents an estimate of the time options are expected to remain outstanding based upon historical analysis. The risk-free rate for periods within the contractual life of the option is based on the U.S. treasury yield curve in effect at the time of grant. The variables used in the Black-Scholes calculation are listed below for the respective periods, no options were granted during the six months ended April 30, 2016:

	Six months ended April 30,
	2016		2015
Expected dividend yield		-		0	%
Expected volatility		-		75 - 76	%
Risk-free interest rate		-		1.4 - 1.6	%
Expected term (years)		-		4 - 5

The following table summarizes information about stock option activity for the six months ended April 30, 2016:  

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value ($M)
Outstanding and expected to vest at October 31, 2015		4,111,896	$	1.86		7.26	$	0.2
Granted		-	$	-
Forfeited		(302,428)	$	3.17
Exercised		-	$	-
Outstanding and expected to vest at April 30, 2016		3,809,468	$	1.75		4.14	$	-
Exercisable at April 30, 2016		3,220,395	$	1.77		3.71	$	-

The weighted average fair value per option granted during the six months ended April 30, 2016 and 2015 was $0 and $1.68, respectively. The total intrinsic value of options (which is the amount by which the stock price exceeded the exercise price of the options on the date of exercise) exercised during the six months ended April 30, 2016 and 2015 was $0 and $35,000, respectively. During the six months ended April 30, 2016 and 2015, the amount of cash received from the exercise of stock options was $0 and $49,000, respectively.

The Company granted no options to non-employees during the six months ended April 30, 2016 and 2015.

At April 30, 2016, there was approximately $0.4 million of total unrecognized compensation cost related to non-vested stock option awards which is expected to be recognized over a weighted-average period of 0.6 years. There were 202,904 and 469,092 options that became vested during the six months ended April 30, 2016 and 2015, respectively, with the total fair value of these awards of approximately $0.3 million and $0.7 million, respectively.

The following table shows information about outstanding stock options at April 30, 2016:

				Options Outstanding						Options Exercisable
						Weighted
						Average		Weighted				Weighted
Range of				Shares		Remaining		Average				Average
Exercise Prices				Outstanding		Contractual Term		Exercise Price		Shares		Exercise Price
$	-	$	1.01		415,005		2.59	$	0.91		415,005	$	0.91
$	1.03	$	1.23		142,486		6.96	$	1.06		85,950	$	1.04
$	1.28	$	1.28		540,900		7.56	$	1.28		540,900	$	1.28
$	1.30	$	1.34		522,013		3.34	$	1.32		275,513	$	1.30
$	1.41	$	1.70		144,421		2.77	$	1.47		94,846	$	1.50
$	1.75	$	1.75		981,752		1.29	$	1.75		981,752	$	1.75
$	1.76	$	2.13		466,819		7.47	$	2.06		335,802	$	2.04
$	2.28	$	3.73		430,107		5.42	$	2.77		324,662	$	2.93
$	3.95	$	4.99		163,879		2.25	$	4.10		163,879	$	4.10
$	5.99	$	5.99		2,086		5.25	$	5.99		2,086	$	5.99
$	-	$	5.99		3,809,468		4.14	$	1.75		3,220,395	$	1.77

XML

EMPLOYEE BENEFITS

6 Months Ended

Apr. 30, 2016

Compensation and Retirement Disclosure [Abstract]

Pension and Other Postretirement Benefits Disclosure [Text Block]

8. EMPLOYEE BENEFITS

In 1996, the Company established the Crossroads Systems, Inc. 401(k) Savings Plan (the “Savings Plan”), which is a qualified plan under section 401(k) of the Internal Revenue Code.  All employees who have attained 18 years of age are eligible to enroll in the Savings Plan.   The Company may make matching contributions to those employees participating in the Savings Plan based upon Company productivity and profitability. Company contributions vest over a period of six years.  In October 2000, the Company adopted a new 401(k) Savings Plan that meets all of the criteria set forth above in the savings plan.  The Company made matching contributions of $82,000 and $93,000 during the six months ended April 30, 2016 and 2015, respectively.

XML

RELATED PARTY TRANSACTIONS

6 Months Ended

Apr. 30, 2016

Related Party Transactions [Abstract]

Related Party Transactions Disclosure [Text Block]

9. RELATED PARTY TRANSACTIONS

2015 Private Placement

On January 27, 2015, the Company entered into placement agency agreements with certain accredited investors for the issuance and sale in a private placement (the “2015 Private Placement”) of an aggregate of 3,071,739 units, at a purchase price of $2.30 per unit for net aggregate proceeds of approximately $7.1 million before expenses. Each unit consisted of one share of common stock and warrants to purchase one-half of a share of common stock at an exercise price of $2.76 per whole share. Lone Star Value Investors, LP (“Lone Star Value LP”), controlled by Jeffrey E. Eberwein, Crossroads’ Chairman of the Board of Directors at the time, acquired 350,000 units in the placement for approximately $0.8 million.

2015 Common Stock Rights Offering

On July 29, 2015, the Company completed a Rights Offering for the Company’s common stock, accepting subscriptions for 3,933,879 shares of common stock at $1.25 per share, for aggregate gross proceeds of approximately $4.9 million. Lone Star Value LP, controlled by Jeffrey E. Eberwein, Crossroads’ Chairman of the Board of Directors at the time, acquired 1,537,907 shares in the Rights Offering for approximately $1.9 million pursuant to the terms of the Rights Offering.

Discontinued operations consideration paid

During the three months ended April 30, 2016 the Company’s Board of Directors approved a payment to the Series F Preferred Shareholders of the greater of 50% of the net proceeds from the sale of the business or $1.0 million. The sale of the business required a 70% approval of the Series F Preferred Shareholders. The $1.0 million payment was recognized as an expense of selling the business.

XML

PREFERRED STOCK RIGHTS

6 Months Ended

Apr. 30, 2016

Preferred Stock Rights [Abstract]

Preferred Stock Rights Disclosure [Text Block]

10. PREFERRED STOCK RIGHTS

On May 23, 2014, the Company's Board of Directors adopted a tax benefit preservation plan (the “Plan”). The Plan is intended to diminish the risk that the Company’s ability to use NOLs to reduce future federal income tax obligations may become substantially limited due to an “ownership change,” as defined in Section 382 of the Internal Revenue Code. The Board of Directors authorized and declared a dividend distribution of one right for each outstanding share of common stock, par value $0.001 per share, and Series F Preferred Stock, par value $0.001 per share, of the Company to stockholders of record as of the close of business on June 4, 2014. Each right entitles the registered holder to purchase from the Company one one-thousandth of a share of Series G Participating Preferred Stock, par value $0.001 per share, of the Company at an exercise price of $14.00 per one one-thousandth of a share of Series G Participating Preferred Stock, subject to adjustment.

The rights will become exercisable following (i) the 10th business day (or such later date as may be determined by the Board of Directors) after the public announcement that an acquiring person has acquired beneficial ownership of 4.99% or more of the common stock (calculated pursuant to the Plan) or (ii) the 10th business day (or such later date as may be determined by the board) after a person or group announces a tender or exchange offer that would result in ownership by a person or group of 4.99% or more of the common stock (calculated pursuant to the Plan).

In addition, upon the occurrence of certain events, the exercise price of the rights would be adjusted and holders of the rights (other than rights owned by an acquiring person or group) would be entitled to purchase common stock at approximately half of market value. Given the potential adjustment of the exercise price of the rights, the rights could cause substantial dilution to a person or group that acquires 4.99% or more of the Company's common stock on terms not approved by the Company's Board of Directors.

No rights were exercisable at April 30, 2016. There is no impact to the Company's financial results as a result of the adoption of the Plan for the six months ended April 30, 2016 or 2015. 

XML

SUBSEQUENT EVENTS

6 Months Ended

Apr. 30, 2016

Subsequent Events [Abstract]

Subsequent Events [Text Block]

11. SUBSEQUENT EVENTS

On May 25, 2016, the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the outstanding shares of the Company’s common stock at a ratio of one-for-twenty at the Company’s annual meeting of stockholders. The Company anticipates the effective date of this stock split to be June 20, 2016.

XML

ORGANIZATION AND BASIS OF PRESENTATION (Policies)

6 Months Ended

Apr. 30, 2016

Organization, Consolidation and Presentation Of Financial Statements [Abstract]

Consolidation, Policy [Policy Text Block]

Principles of Consolidation and presentation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation.

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has accumulated significant losses as it has been developing its current and next generation products. The Company believes that cash flow from operations, customer reimbursed expenses, and proceeds from the sale of common and preferred stock will be sufficient to fund the anticipated operations for the next 12 months.  These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern for a reasonable period of time.

The investment in KIP CR P1 LP (which we refer to as the “partnership”), of which the Company is a limited partner and of which an affiliate of Fortress Investment Group LLC (“Fortress”) is the general partner, is accounted for using the equity method. The partnership holds the Company’s non’972 patent portfolio. The current investment balance is nominal at April 30, 2016.

Use of Estimates, Policy [Policy Text Block]

Use of Estimates

The preparation of the consolidated financial statements in conformity with generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates, and such differences may be material to the consolidated financial statements.

Reclassification, Policy [Policy Text Block]

Reclassification

Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassification includes assets, liabilities, and certain expenses in sales and marketing, research and development, and general and administrative related to discontinued operations. The amounts for the prior periods have been reclassified to be consistent with the current period presentation and have no impact on previously reported financials.

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash, Cash Equivalents, and Restricted Cash

Cash, cash equivalents, and restricted cash consist of cash on deposit and highly liquid investments with original maturities of 90 days or less at date of purchase. While the Company’s cash and cash equivalents are on deposit with high quality FDIC and Association of German Banks insured financial institutions, at times such deposits exceed insured limits. As of April 30, 2016, total uninsured deposits were $5.8 million. The Company has not experienced any losses in such accounts.

Restricted cash amounted to $3.1 million. The balance consists of $2.9 million in cash held from the sale of a portion of the Company’s IP revenue stream, and $0.2 million in connection with a letter of credit on the lease of the Company headquarters.

Revenue Stream Sale [Policy Text Block]

IP Revenue Stream Sale

On October 30, 2015, the Company entered into an agreement with TQ Zeta LLC, an affiliate of Techquity, and Intrepidus Holdings LLC (collectively, “Techquity”), in which Techquity will share in the revenue generated from the ‘972 patent litigation. For consideration of $10.0 million received by the Company, Techquity received the rights to 52% of the first $20 million in licenses, settlements or other awards related to the ‘972 patents, 40% of the amounts between $20 and $100 million, and 12% of all amounts above $100 million in aggregate licensing, settlements or other awards. Proceeds from the TQ Zeta agreement are restricted to approved legal expenditures as defined in the agreement. During the three and six months ended April 30, 2016, the Company recognized $0.6 and $3.3 million in other income, respectively, $2.9 million is held in deferred revenue and restricted cash. Included in the amount recognized as revenue during the three and six months ended April 30, 2016 is $0.2 million recorded in liabilities, reducing restricted cash. The Company will recognize other income from this transaction as the authorized expenditures are made with the unspent balance being reflected as deferred revenue.

Contracts To Modify Or Customize Products, Policy [Policy Text Block]

Contracts to Modify or Customize Products

The Company has entered into contracts with certain customers to significantly modify or customize products. In accounting for such arrangements, we first look to the guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 985-605, Software - Revenue Recognition (“ASC 985-605”), and then ASC Subtopic 605-25, Revenue Recognition – Multiple-Element Arrangements, to determine the appropriate accounting elements in the arrangement.  The Company then considers the appropriate recognition model for each accounting element based on the nature of the element and apply the guidance in ASC Subtopic 605-35, Revenue Recognition – Construction-Type and Production-Type Contracts, ASC Subtopic 985-60, ASC Subtopic 605-15, Revenue Recognition – Products, or ASC Subtopic 605-20, Revenue Recognition – Services, as applicable.  Amounts allocated to the modification/customization service element are evaluated for classification in the consolidated statement of operations as either revenue or reduction of research and development expense based on the following considerations: whether and in what circumstances the consideration received is refundable, ownership of the final product and intellectual property rights to develop the product, and exclusivity of the final product.

Earnings Per Share, Policy [Policy Text Block]

Computation of Net Loss Per Share

Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share is computed by giving effect to all dilutive potential common shares that were outstanding during the period. Basic earnings per share excludes the dilutive effect of common stock equivalents such as stock options and warrants, while earnings per share, assuming dilution, includes such dilutive effects. Future weighted-average shares outstanding calculations will be impacted by the following factors, among others: (i) the ongoing issuance of common stock associated with stock option and warrant exercises; (ii) any fluctuations in the Company’s stock price, which could cause changes in the number of common stock equivalents included in the earnings per share, assuming dilution computation; and (iii) the issuance of common stock to effect business combinations should the Company enter into such transactions.

The Company has excluded all outstanding common stock equivalents from the calculation of diluted net loss per share because all such common stock equivalents are antidilutive for all periods presented. The total number of common stock equivalents excluded from the diluted net loss per common share calculation was 13,776,052 and 13,411,599 for the six months ended April 30, 2016 and 2015, respectively. The dilutive common stock equivalents for the six months ended April 30, 2016 include warrants to purchase 7,375,327 shares of common stock, 2,591,257 shares of preferred stock, which are excluded until converted to common shares (Note 6), and stock options to purchase 3,809,468 shares of common stock.

Net loss available to common stockholders is calculated by deducting from net income, preferred dividends paid and accrued of $78,000 and $129,000 for the three and six months ended April 30, 2016, respectively.

New Accounting Pronouncements, Policy [Policy Text Block]

Recently Issued Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) amended the existing accounting standards for revenue recognition. The amendments are based on the principle that revenue should be recognized in accordance to the transfer of promised goods or services to customers, reflecting the amount of consideration to which the entity expects to be entitled in exchange for those goods or services. In August 2015, the FASB issued an accounting standard update for a one-year deferral of the effective date, with an option of applying the standard on the original effective date, which for Crossroads is the first quarter of fiscal 2018. In accordance with this deferral, the Company is required to adopt these amendments in the first quarter of fiscal 2019. The amendments may be applied retrospectively to each prior period presented or retrospectively with the cumulative effect recognized as of the date of initial application. The Company is continuing to evaluate the impact of these amendments and the transition alternatives on its consolidated financial statements and disclosures. 

The Company has implemented all new accounting pronouncements that are in effect and that may impact its consolidated financial statements. The Company does not believe that there are any new accounting pronouncements that have been issued that might have a material impact on its consolidated financial position or results of operations.

XML

ACCRUED EXPENSES AND DEFERRED REVENUE (Tables)

6 Months Ended

Apr. 30, 2016

Payables and Accruals [Abstract]

Schedule of Accrued Liabilities [Table Text Block]

Accrued expenses consist of the following (in thousands):

	April 30,		October 31,
	2016		2015
	(unaudited)
Payroll related	$	162	$	837
Professional services		340		657
Deferred rent		-		184
Warranty reserve		-		5
Other		89		44
	$	591	$	1,727

Deferred Revenue, by Arrangement, Disclosure [Table Text Block]

Deferred revenue, current portion, consists of the following (in thousands):

	April 30,		October 31,
	2016		2015
	(unaudited)
License	$	104	$	135
Deferred revenue stream sale		2,906		6,208
	$	3,010	$	6,343

XML

DISCONTINUED OPERATIONS (Tables)

6 Months Ended

Apr. 30, 2016

Discontinued Operations and Disposal Groups [Abstract]

Schedule Of Disposal Groups Including Discontinued Operations Assets And Liabilities Transferred For Consideration Received [Table Text Block]

The assets and liabilities transferred for consideration received were (in thousands, at book value, unaudited):

Cash Received	$	1,852
Cash paid to Series F Convertible Preferred shareholders		(1,000)
Net cash received		852
Fixed Assets		(499)
Inventory		(386)
Other Comprehensive Income		(110)
Expenses incurred		(79)
Deferred Revenue		1,795
Other Assets and Liabilities		198
Net gain on sale of discontinued operations	$	1,771

Disposal Groups, Including Discontinued Operations [Table Text Block]

The table below presents the amounts by balance sheet classification (in thousands):

	April 30,		October 31,
	2016		2015
Assets	(unaudited)		(unaudited)
Current assets:
Accounts receivable, net	$	-	$	976
Inventories		-		437
Prepaids expenses, and other current assets		-		131
Total current assets		-		1,544
Property and equipment, net		-		533
Other assets		-		30
Total assets	$	-	$	2,107
Liabilities
Current liabilities:
Accounts payable		-		400
Accrued expenses		-		68
Deferred revenue		-		891
Total current liabilities		-		1,359
Long term deferred revenue		-		596
Total liabilities	$	-	$	1,955

The amounts in the statement of operations that are part of the discontinued operations are summarized in the following table (in thousands):

	Three Months Ended				Six Months Ended
	April 30,				April 30,
	2016		2015		2016		2015
Revenue:	(unaudited)		(unaudited)		(unaudited)		(unaudited)
Product	$	-	$	584	$	859	$	1,446
IP License, royalty and other		(63)		946		923		2,053
Total revenue		(63)		1,530		1,782		3,499
Cost of revenue:
Product		-		220		309		502
IP License, royalty and other		41		176		275		433
Total cost of revenue		41		396		584		935
Gross profit		(104)		1,134		1,198		2,564
Operating expenses:
Sales and marketing		452		829		1,275		1,700
Research and development		638		1,079		1,735		2,351
Total operating expenses		1,090		1,908		3,010		4,051
(Loss) income from discontinued operations	$	(1,194)	$	(774)	$	(1,812)	$	(1,487)

XML

STOCKHOLDERS' EQUITY (Tables)

6 Months Ended

Apr. 30, 2016

Stockholders Equity Note [Abstract]

Schedule of Stockholders Equity Note, Warrants or Rights [Table Text Block]

The Company has the following common stock warrants outstanding at April 30, 2016:

Warrant Transaction	Warrants Outstanding		Weighted Average Exercise Price
2013 Private Placement		2,439,585	$	2.00
2013 Fortress Credit Agreement		1,748,218	$	2.06
2014 Private Placement		1,193,860	$	2.45
2015 Common Stock Offering		1,993,664	$	2.76
Total Warrants		7,375,327

XML

STOCK OPTIONS AND STOCK BASED COMPENSATION (Tables)

6 Months Ended

Apr. 30, 2016

Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

The Company realized stock-based compensation expense for all awards issued under the Company’s stock plans in the following line items in the consolidated statements of operations:

	Six months ended April 30,
	2016		2015
General and administrative	$	348	$	332
Discontinued operations		103		204
Total stock-based compensation	$	451	$	536

Variables Used In Black Sholes Calculation [Table Text Block]

The variables used in the Black-Scholes calculation are listed below for the respective periods, no options were granted during the six months ended April 30, 2016:

	Six months ended April 30,
	2016		2015
Expected dividend yield		-		0	%
Expected volatility		-		75 - 76	%
Risk-free interest rate		-		1.4 - 1.6	%
Expected term (years)		-		4 - 5

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

The following table summarizes information about stock option activity for the six months ended April 30, 2016:  

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value ($M)
Outstanding and expected to vest at October 31, 2015		4,111,896	$	1.86		7.26	$	0.2
Granted		-	$	-
Forfeited		(302,428)	$	3.17
Exercised		-	$	-
Outstanding and expected to vest at April 30, 2016		3,809,468	$	1.75		4.14	$	-
Exercisable at April 30, 2016		3,220,395	$	1.77		3.71	$	-

Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans To Employees and Non Employees By Exercise Price Range [Table Text Block]

The following table shows information about outstanding stock options at April 30, 2016:

				Options Outstanding						Options Exercisable
						Weighted
						Average		Weighted				Weighted
Range of				Shares		Remaining		Average				Average
Exercise Prices				Outstanding		Contractual Term		Exercise Price		Shares		Exercise Price
$	-	$	1.01		415,005		2.59	$	0.91		415,005	$	0.91
$	1.03	$	1.23		142,486		6.96	$	1.06		85,950	$	1.04
$	1.28	$	1.28		540,900		7.56	$	1.28		540,900	$	1.28
$	1.30	$	1.34		522,013		3.34	$	1.32		275,513	$	1.30
$	1.41	$	1.70		144,421		2.77	$	1.47		94,846	$	1.50
$	1.75	$	1.75		981,752		1.29	$	1.75		981,752	$	1.75
$	1.76	$	2.13		466,819		7.47	$	2.06		335,802	$	2.04
$	2.28	$	3.73		430,107		5.42	$	2.77		324,662	$	2.93
$	3.95	$	4.99		163,879		2.25	$	4.10		163,879	$	4.10
$	5.99	$	5.99		2,086		5.25	$	5.99		2,086	$	5.99
$	-	$	5.99		3,809,468		4.14	$	1.75		3,220,395	$	1.77

XML

ORGANIZATION AND BASIS OF PRESENTATION (Details Textual) - USD ($)	3 Months Ended	6 Months Ended		12 Months Ended
	Apr. 30, 2016	Apr. 30, 2016	Apr. 30, 2015	Oct. 31, 2015
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share, Amount		13,776,052	13,411,599
Cash, Uninsured Amount	$ 5,800,000	$ 5,800,000
Restricted Cash and Cash Equivalents	3,122,000	3,122,000		$ 6,478,000
Restricted Investments	2,900,000	2,900,000
Cash Collateral for Borrowed Securities	200,000	200,000
Proceeds from Sale of Intangible Assets				$ 10,000,000
Sale Of Intangible Assets, Percentage Of Patent Licenses Issued In First Issue				52.00%
Sale Of Intangible Assets, Maximum Amount Of Patent Licenses Issued In First Issue				$ 20,000,000
Sale Of Intangible Assets, Percentage Of Patent Licenses Issued In Second Issue				40.00%
Sale Of Intangible Assets, Minimum Amount Of Patent Licenses Issued In Second Issue				$ 20,000,000
Sale Of Intangible Assets, Maximum Amount Of Patent Licenses Issued In Second Issue				$ 100,000,000
Sale Of Intangible Assets, Percentage Of Patent Licenses Issued In Third Issue				12.00%
Other Income	600,000	3,300,000
Deferred Revenue	200,000	200,000
Preferred Stock, Amount of Preferred Dividends in Arrears	$ 78,000	$ 129,000
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share, Amount		7,375,327
Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share, Amount		2,591,257
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share, Amount		3,809,468

XML

ACCRUED EXPENSES AND DEFERRED REVENUE (Details) - USD ($) $ in Thousands	Apr. 30, 2016	Oct. 31, 2015
Deferred Revenue Arrangement [Line Items]
Payroll related	$ 162	$ 837
Professional services	340	657
Deferred rent	0	184
Warranty reserve	0	5
Other	89	44
Accrued Liabilities Current	$ 591	$ 1,727

XML

ACCRUED EXPENSES AND DEFERRED REVENUE (Details 1) - USD ($) $ in Thousands	Apr. 30, 2016	Oct. 31, 2015
Deferred Revenue Arrangement [Line Items]
Deferred revenue	$ 3,010	$ 6,343
License [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenue	104	135
Deferred revenue stream sale [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenue	$ 2,906	$ 6,208

XML

ACCRUED EXPENSES AND DEFERRED REVENUE (Details Textual) - USD ($) $ in Millions	Apr. 30, 2016	Oct. 31, 2015
Deferred Revenue Arrangement [Line Items]
Accrued Bonuses, Current	$ 0.1	$ 0.4

XML

COMMITMENTS AND CONTINGENCIES (Details Textual) $ in Millions	6 Months Ended
	Apr. 30, 2016 USD ($)
Commitments And Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	$ 200.0
Dot Hill Systems Corp [Member]
Commitments And Contingencies [Line Items]
Due from Related Parties, Current	$ 1.0

XML

DISCONTINUED OPERATIONS (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 30, 2016	Apr. 30, 2015	Apr. 30, 2016	Apr. 30, 2015
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash Received			$ 1,852
Cash paid to Series F Convertible Preferred shareholders			(1,000)
Net cash received			852	$ 0
Fixed Assets	$ (499)		(499)
Inventory	(386)		(386)
Other Comprehensive Income			(110)
Expenses incurred			(79)
Deferred Revenue	1,795		1,795
Other Assets and Liabilities	198		198
Net gain on sale of discontinued operations	$ 1,771	$ 0	$ 1,771	$ 0

XML

DISCONTINUED OPERATIONS (Details 1) - USD ($) $ in Thousands	Apr. 30, 2016	Oct. 31, 2015
Current assets:
Accounts receivable, net	$ 0	$ 976
Inventories	0	437
Prepaids expenses, and other current assets	0	131
Total current assets	0	1,544
Property and equipment, net	0	533
Other assets	0	30
Total assets	0	2,107
Current liabilities:
Accounts payable	0	400
Accrued expenses	0	68
Deferred revenue	0	891
Total current liabilities	0	1,359
Long term deferred revenue	0	596
Total liabilities	$ 0	$ 1,955

XML

DISCONTINUED OPERATIONS (Details 2) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 30, 2016	Apr. 30, 2015	Apr. 30, 2016	Apr. 30, 2015
Revenue:
IP License, royalty and other	$ 210	$ 190	$ 420	$ 392
Cost of revenue:
IP License, royalty and other	49	16	100	53
Gross profit	161	174	320	339
Operating expenses:
Total operating expenses	1,356	2,638	3,705	4,066
(Loss) income from discontinued operations	1,194	774	1,812	1,487
Discontinued Operations [Member]
Revenue:
Product	0	584	859	1,446
IP License, royalty and other	(63)	946	923	2,053
Total revenue	(63)	1,530	1,782	3,499
Cost of revenue:
Product	0	220	309	502
IP License, royalty and other	41	176	275	433
Total cost of revenue	41	396	584	935
Gross profit	(104)	1,134	1,198	2,564
Operating expenses:
Sales and marketing	452	829	1,275	1,700
Research and development	638	1,079	1,735	2,351
Total operating expenses	1,090	1,908	3,010	4,051
(Loss) income from discontinued operations	$ (1,194)	$ (774)	$ (1,812)	$ (1,487)

XML

DISCONTINUED OPERATIONS (Details Textual) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Apr. 30, 2016	Apr. 30, 2016
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase and Assignment Agreement,Inception Date		Mar. 22, 2016
Proceeds from Divestiture of Businesses		$ 1,852
Cash Divested from Deconsolidation		(1,000)
Purchase and Assignment Agreement [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from Divestiture of Businesses		1,900
Series F Preferred Stock [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash Divested from Deconsolidation	$ 1,000	$ 1,000

XML

STOCKHOLDERS' EQUITY (Details) - $ / shares	Apr. 30, 2016	Jan. 27, 2015	Mar. 31, 2014	Jul. 22, 2013	Mar. 22, 2013
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	7,375,327
2013 Private Placement Warrant [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	2,439,585
Weighted Average Exercise Price (in dollars per share)	$ 2.00				$ 2.0625
2013 Fortress Credit Agreement Warrant [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	1,748,218			1,454,545
Weighted Average Exercise Price (in dollars per share)	$ 2.06			$ 2.0625
2014 Private Placement Warrant [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	1,193,860
Weighted Average Exercise Price (in dollars per share)	$ 2.45		$ 2.45
2015 Common Stock Offering [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding (in shares)	1,993,664	1,993,664
Weighted Average Exercise Price (in dollars per share)	$ 2.76	$ 2.76

XML

STOCKHOLDERS' EQUITY (Details Textual)	1 Months Ended						6 Months Ended
	Aug. 31, 2015 $ / shares shares	Jul. 28, 2015 USD ($) $ / shares shares	Jan. 27, 2015 USD ($) $ / shares shares	Mar. 31, 2014 USD ($) $ / shares shares	Jul. 22, 2013 USD ($) $ / shares $ / Rate shares	Mar. 22, 2013 USD ($) $ / shares $ / Rate shares	Apr. 30, 2016 USD ($) $ / shares shares	Apr. 30, 2015 USD ($) shares	Oct. 31, 2015 shares
Class of Stock [Line Items]
Payments of Stock Issuance Costs | $		$ 400,000
Common Stock, Shares, Issued (in shares)							24,509,435		24,182,524
Preferred Stock, Shares Authorized							25,000,000		25,000,000
Class of Warrant or Right, Outstanding							7,375,327
Common Stock, Shares Subscribed but Unissued		3,933,879
Common Stock, Value, Subscriptions | $		$ 4,900,000
Subscription Price Per Share | $ / shares		$ 1.25
Purchase Of Common Stock Shares		0.50
2013 Private Placement Warrant [Member]
Class of Stock [Line Items]
Exercise Price Per Share Of Common Stock Issued By Conversion Of Warrants | $ / shares	$ 0.2019
Fair Value Of Warrants | $						$ 2,284,000
Fair Value Assumptions, Expected Dividend Rate						0.00%
Fair Value Assumptions, Expected Volatility Rate						63.00%
Fair Value Assumptions, Risk Free Interest Rate						0.82%
Fair Value Assumptions, Expected Term						5 years
Securities Purchase Agreement, Exercise Price Of Warrants Issued | $ / shares						$ 2.00
Warrants Convertible Beneficial Conversion Feature | $						$ 1,090,000	$ 126,911
Common Stock Dividends, Shares								67,781
Stock Issued During Period, Value, Stock Dividend | $							$ 302,000	$ 169,000
Fair Value of Warrant Liability | $						$ 1,543,000
Class of Warrant or Right, Outstanding							2,439,585
Accrued Liabilities for Commissions, Expense and Taxes | $							$ 88,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares						$ 2.0625	$ 2.00
2013 Fortress Credit Agreement Warrant [Member]
Class of Stock [Line Items]
Exercise Price Per Share Of Common Stock Issued By Conversion Of Warrants | $ / shares	0.2019
Fair Value Of Warrants | $					$ 1,374,000
Securities Purchase Agreement, Price Per Unit Of Units Issuable | $ / Rate					2.0625
Fair Value Of Warrants, Per Share | $ / shares					$ 1.0625
Class of Warrant or Right, Outstanding					1,454,545		1,748,218
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares					$ 2.0625		$ 2.06
2014 Private Placement Warrant [Member]
Class of Stock [Line Items]
Stock Issued During Period Shares New Issues One				1,986,622
Shares Issued, Price Per Share | $ / shares				$ 2.2565
Number Of Common Stock, Shares Granted By Issue Of Warrants Under Private Placement				993,311
Exercise Price Per Share Of Common Stock Issued By Conversion Of Warrants | $ / shares	$ 0.2019			$ 2.45
Payments of Stock Issuance Costs | $				$ 200,000
Fair Value Of Warrants | $				$ 1,100,000
Fair Value Assumptions, Expected Dividend Rate				0.00%
Fair Value Assumptions, Expected Volatility Rate				74.00%
Fair Value Assumptions, Risk Free Interest Rate				1.64%
Fair Value Assumptions, Expected Term				2 years 6 months
Class of Warrant or Right, Outstanding							1,193,860
Proceeds from Issuance of Private Placement | $				$ 4,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares				$ 2.45			$ 2.45
2015 Common Stock Offering
Class of Stock [Line Items]
Stock Issued During Period Shares New Issues One			3,071,739
Shares Issued, Price Per Share | $ / shares			$ 2.30
Number Of Common Stock, Shares Granted By Issue Of Warrants Under Private Placement	0.2019		1,658,760
Exercise Price Per Share Of Common Stock Issued By Conversion Of Warrants | $ / shares			$ 2.76
Payments of Stock Issuance Costs | $			$ 1,100,000
Fair Value Of Warrants | $			$ 1,900,000
Fair Value Assumptions, Expected Dividend Rate			0.00%
Fair Value Assumptions, Expected Volatility Rate			75.00%
Fair Value Assumptions, Risk Free Interest Rate			1.55%
Fair Value Assumptions, Expected Term			4 years
Class of Warrant or Right, Outstanding			1,993,664				1,993,664
Proceeds from Issuance of Private Placement | $			$ 7,100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares			$ 2.76				$ 2.76
Series F1 Convertible Preferred Stock [Member] | 2013 Private Placement Warrant [Member]
Class of Stock [Line Items]
Equity Method Investment, Ownership Percentage							9.99%
Series F2 Convertible Preferred Stock [Member] | 2013 Private Placement Warrant [Member]
Class of Stock [Line Items]
Equity Method Investment, Ownership Percentage							4.99%
Series F Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Common Stock, Shares, Issued (in shares)							200,000
Preferred Stock, Dividend Rate, Percentage							5.00%
Certificate Of Designation [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized							4,500,000
Certificate Of Designation [Member] | Series F1 Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized							3,750,000
Preferred Stock, Voting Rights							Such beneficial ownership limitations may be increased or decreased by a holder of Sub-Series F-1 to any percentage not in excess of 19.99% after providing notice of such increase or decrease to the Company. For as long as at least 90% of the aggregate number of shares of Sub-Series F-1 issued on the original issue date are outstanding, the holders of such Sub-Series F-1, voting as a single class, will be entitled to elect two directors of the Company. If less than 90%, but at least 20%, of such shares of Sub-Series F-1 are outstanding, such holders, voting as a single class, will be entitled to elect one director of the Company.
Certificate Of Designation [Member] | Series F2 Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized							750,000
Investors [Member]
Class of Stock [Line Items]
Securities Purchase Agreement, Price Per Unit Of Units Issuable | $ / Rate						2.0625
Securities Purchase Agreement, Value Of Units Issuable | $						$ 8,600,000
Securities Purchase Agreement, Proceeds From Issuance Of Units | $						$ 7,900,000
Investors [Member] | 2013 Private Placement Warrant [Member]
Class of Stock [Line Items]
Securities Purchase Agreement, Number Of Units Issuable						4,231,154
Securities Purchase Agreement, Number Of Warrants Issued						2,282,754
Units Par Or Stated Value Per Share | $ / shares						$ 0.001
Units Description						Each unit consists of one share of cumulative5.0% Series F convertible preferred stock
Investor One [Member] | 2013 Private Placement Warrant [Member]
Class of Stock [Line Items]
Securities Purchase Agreement, Exercise Price Of Warrants Issued | $ / shares						$ 2.00
Private Placement [Member] | Investors [Member]
Class of Stock [Line Items]
Securities Purchase Agreement, Units Issuance Cost | $						$ 700,000

XML

STOCK OPTIONS AND STOCK BASED COMPENSATION (Details) - USD ($) $ in Thousands	6 Months Ended
	Apr. 30, 2016	Apr. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation	$ 451	$ 536
Discontinued Operations [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation	103	204
General and administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total stock-based compensation	$ 348	$ 332

XML

STOCK OPTIONS AND STOCK BASED COMPENSATION (Details 1)	6 Months Ended
	Apr. 30, 2016	Apr. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield	0.00%	0.00%
Expected volatility	0.00%
Expected volatility, Minimum		75.00%
Expected volatility, Maximum		76.00%
Risk-free interest rate	0.00%
Risk-free interest rate, Minimum		1.40%
Risk-free interest rate, Maximum		1.60%
Expected term (years)	0 years
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)		4 years
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)		5 years

XML

STOCK OPTIONS AND STOCK BASED COMPENSATION (Details 2) - USD ($)	6 Months Ended	12 Months Ended
	Apr. 30, 2016	Oct. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Outstanding and expected to vest at October 31, 2015	4,111,896
Number of Shares, Granted	0
Number of Shares, Forfeited	(302,428)
Number of Shares, Exercised	0
Number of Shares, Outstanding and expected to vest at April 30, 2016	3,809,468	4,111,896
Exercisable at April 30, 2016	3,220,395
Weighted Average Exercise Price, Outstanding and expected to vest at October 31, 2015 (in dollars per share)	$ 1.86
Weighted Average Exercise Price, Granted (in dollars per share)	0
Weighted Average Exercise Price, Forfeited (in dollars per share)	3.17
Weighted Average Exercise Price, Exercised (in dollars per share)	0
Weighted Average Exercise Price, Outstanding and expected to vest at April 30, 2016 (in dollars per share)	1.75	$ 1.86
Weighted Average Exercise Price, Exercisable at April 30, 2016 (in dollars per share)	$ 1.77
Weighted Average Remaining Contractual Term, Outstanding and expected to vest at end of the period (in years)	4 years 1 month 20 days	7 years 3 months 4 days
Weighted Average Remaining Contractual Term, Exercisable at April 30, 2016 (in years)	3 years 8 months 16 days
Aggregate Intrinsic Value, Outstanding and expected to vest at October 31, 2015	$ 200
Aggregate Intrinsic Value, Outstanding and expected to vest at April 30, 2016	0	$ 200
Aggregate Intrinsic Value, Exercisable at April 30, 2016 (in dollars)	$ 0

XML

STOCK OPTIONS AND STOCK BASED COMPENSATION (Details 3)	6 Months Ended
	Apr. 30, 2016 $ / shares shares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Limit (in dollars per share)	$ 0
Range of Exercise Prices, Upper Limit (in dollars per share)	$ 5.99
Options Outstanding, Shares Outstanding (in shares) | shares	3,809,468
Options Outstanding, Weighted Average Remaining Contractual Term (in years)	4 years 1 month 20 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 1.75
Options Exercisable, Shares (in shares) | shares	3,220,395
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 1.77
Range Of Exercise Prices One [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Limit (in dollars per share)	0
Range of Exercise Prices, Upper Limit (in dollars per share)	$ 1.01
Options Outstanding, Shares Outstanding (in shares) | shares	415,005
Options Outstanding, Weighted Average Remaining Contractual Term (in years)	2 years 7 months 2 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 0.91
Options Exercisable, Shares (in shares) | shares	415,005
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 0.91
Range Of Exercise Prices Two [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Limit (in dollars per share)	1.03
Range of Exercise Prices, Upper Limit (in dollars per share)	$ 1.23
Options Outstanding, Shares Outstanding (in shares) | shares	142,486
Options Outstanding, Weighted Average Remaining Contractual Term (in years)	6 years 11 months 16 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 1.06
Options Exercisable, Shares (in shares) | shares	85,950
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 1.04
Range Of Exercise Prices Three [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Limit (in dollars per share)	1.28
Range of Exercise Prices, Upper Limit (in dollars per share)	$ 1.28
Options Outstanding, Shares Outstanding (in shares) | shares	540,900
Options Outstanding, Weighted Average Remaining Contractual Term (in years)	7 years 6 months 22 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 1.28
Options Exercisable, Shares (in shares) | shares	540,900
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 1.28
Range Of Exercise Prices Four [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Limit (in dollars per share)	1.30
Range of Exercise Prices, Upper Limit (in dollars per share)	$ 1.34
Options Outstanding, Shares Outstanding (in shares) | shares	522,013
Options Outstanding, Weighted Average Remaining Contractual Term (in years)	3 years 4 months 2 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 1.32
Options Exercisable, Shares (in shares) | shares	275,513
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 1.30
Range Of Exercise Prices Five [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Limit (in dollars per share)	1.41
Range of Exercise Prices, Upper Limit (in dollars per share)	$ 1.70
Options Outstanding, Shares Outstanding (in shares) | shares	144,421
Options Outstanding, Weighted Average Remaining Contractual Term (in years)	2 years 9 months 7 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 1.47
Options Exercisable, Shares (in shares) | shares	94,846
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 1.50
Range Of Exercise Prices Six [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Limit (in dollars per share)	1.75
Range of Exercise Prices, Upper Limit (in dollars per share)	$ 1.75
Options Outstanding, Shares Outstanding (in shares) | shares	981,752
Options Outstanding, Weighted Average Remaining Contractual Term (in years)	1 year 3 months 14 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 1.75
Options Exercisable, Shares (in shares) | shares	981,752
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 1.75
Range Of Exercise Prices Seven [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Limit (in dollars per share)	1.76
Range of Exercise Prices, Upper Limit (in dollars per share)	$ 2.13
Options Outstanding, Shares Outstanding (in shares) | shares	466,819
Options Outstanding, Weighted Average Remaining Contractual Term (in years)	7 years 5 months 19 days
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 2.06
Options Exercisable, Shares (in shares) | shares	335,802
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 2.04
Range Of Exercise Prices Eight [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Limit (in dollars per share)	2.28
Range of Exercise Prices, Upper Limit (in dollars per share)	$ 3.73
Options Outstanding, Shares Outstanding (in shares) | shares	430,107
Options Outstanding, Weighted Average Remaining Contractual Term (in years)	5 years 5 months 1 day
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 2.77
Options Exercisable, Shares (in shares) | shares	324,662
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 2.93
Range Of Exercise Prices Nine [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Limit (in dollars per share)	3.95
Range of Exercise Prices, Upper Limit (in dollars per share)	$ 4.99
Options Outstanding, Shares Outstanding (in shares) | shares	163,879
Options Outstanding, Weighted Average Remaining Contractual Term (in years)	2 years 3 months
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 4.10
Options Exercisable, Shares (in shares) | shares	163,879
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 4.10
Range Of Exercise Prices Ten [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Limit (in dollars per share)	5.99
Range of Exercise Prices, Upper Limit (in dollars per share)	$ 5.99
Options Outstanding, Shares Outstanding (in shares) | shares	2,086
Options Outstanding, Weighted Average Remaining Contractual Term (in years)	5 years 3 months
Options Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 5.99
Options Exercisable, Shares (in shares) | shares	2,086
Options Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 5.99

XML

STOCK OPTIONS AND STOCK BASED COMPENSATION (Details Textual) - USD ($)	6 Months Ended
	Apr. 30, 2016	Apr. 30, 2015	Oct. 31, 2015
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Options To Employees and Non Employees Outstanding Number (in shares)	3,809,468		4,111,896
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)	$ 0	$ 1.68
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value	$ 0	$ 35,000
Proceeds from Stock Options Exercised	$ 0	$ 49,000
Expected Weighted Average Period Of Recognition Of Compensation Cost Related To Stock Options To Employees and Non Employees	7 months 6 days
Stock Options Vested By Shares To Employees and Non Employees During Period	202,904	469,092
Stock Options Vested To Value Of Employees and Non Employees During Period	$ 300,000	$ 700,000
Number of Shares, Granted	0
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	$ 400,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures, Total	0	117,577
Stock Option Plan 1999 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Options To Employees and Non Employees Outstanding Number (in shares)	285,683
Stock Options Authorized To Be Issued To Employees and Non Employees	3,809,468
Stock Option Plan 2010 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Options Vested By Shares To Employees and Non Employees During Period	3,220,395
Common Stock Shares Granted	0	0
Number of Shares, Granted	414,172
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights	The 2010 Plan options generally become exercisable over a four-year period (vesting 25% after one year, the remaining 75% vesting quarterly thereafter) and expire after ten years. The majority of the employee incentive stock option grants vest on a schedule of 25% at the end of six months and 12.5% thereafter until fully vested.
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	526,741
Common Stock, Capital Shares Reserved for Future Issuance	785,302
Stock Option Plan 2010 [Member] | Board Of Directors [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Options To Employees and Non Employees Outstanding Number (in shares)	3,523,785
Stock Options Authorized To Be Issued To Employees and Non Employees	5,250,000
Number of Shares, Granted	5,304,943

XML

EMPLOYEE BENEFITS (Details Textual) - USD ($)	6 Months Ended
	Apr. 30, 2016	Apr. 30, 2015
401(k) Savings Plan [Member]
Defined Contribution Plan Disclosure [Line Items]
Defined Contribution Plan, Employer Discretionary Contribution Amount	$ 82,000	$ 93,000

XML

RELATED PARTY TRANSACTIONS (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended		3 Months Ended	6 Months Ended
	Jul. 29, 2015	Jan. 27, 2015	Apr. 30, 2016	Apr. 30, 2016	Jul. 28, 2015
Related Party Transaction [Line Items]
Common Stock, Shares Subscribed but Unissued					3,933,879
Selling Expense			$ 1,000
Cash Divested from Deconsolidation				$ (1,000)
Series F Preferred Stock [Member]
Related Party Transaction [Line Items]
Approval For Sale Of Business,Percentage			70.00%
Percentage Of Net Proceeds for Shareholders			50.00%
Cash Divested from Deconsolidation			$ 1,000	$ 1,000
2015 Private Placement Warrant [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Shares, New Issues		3,071,739
Shares Issued, Price Per Share		$ 2.30
Proceeds from Issuance of Private Placement	$ 4,900	$ 7,100
Exercise Price Per Share Of Common Stock Issued By Conversion Of Warrants	$ 1.25	$ 2.76
Stock Issued During Period, Shares, Acquisitions	1,537,907	350,000
Adjustments to Additional Paid in Capital, Warrant Issued	$ 1,900	$ 800
Common Stock, Shares Subscribed but Unissued	3,933,879

XML

PREFERRED STOCK RIGHTS (Details Textual) - $ / shares	6 Months Ended
	Apr. 30, 2016	Oct. 31, 2015
Class of Stock [Line Items]
Preferred Stock, Participation Rights	one right for each outstanding share of common stock, par value $0.001 per share, and Series F Preferred Stock, par value $0.001 per share, of the Company to stockholders of record as of the close of business on June 4, 2014.
Preferred Stock, Par Or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Rights Entitlement	to purchase from the Company one one-thousandth of a share of Series G Participating Preferred Stock
Preferred Stock Rights Exercisable, Beneficial Ownership Percentage of Common Stock	4.99%
Series G Participating Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Par Or Stated Value Per Share	$ 0.001
Preferred Stock, Exercise Price Per One One-Thousandth	$ 14.00